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ABSTRACT 
 
       Viral invasion of the central nervous system (CNS) and development of neurological 
symptoms is a characteristic of many retroviruses. The mechanism by which retrovirus 
infection causes neurological dysfunction has yet to be fully elucidated. Given the 
complexity of the retrovirus-mediated neuropathogenesis, studies using small animal 
models are extremely valuable. Our laboratory has used a mutant moloney murine 
leukemia retrovirus, ts1-mediated neurodegneration. We hypothesize that astrocytes play 
an important role in ts1-induced neurodegeneration since they are retroviral reservoirs and 
supporting cells for neurons. It has been shown that ts1 is able to infect astrocytes in vivo 
and in vitro. Astrocytes, the dominant cell population in the CNS, extend their end feet to 
endothelial cells and neuronal synapse to provide neuronal support. Signs of oxidative 
stress in the ts1-infected CNS have been well-documented from previous studies.  
       After viral infection, retroviral DNA is generated from its RNA genome and integrated 
into the host genome. In this study, we identified the life cycle of ts1 in the infected 
astrocytes. During the infection, we observed reactive oxygen species (ROS) upregulations: 
one at low levels during the early infection phase and another at high levels during the late 
infection phase. Initially we hypothesized that p53 might play an important role in ts1-
mediated astrocytic cell death. Subsequently, we found that p53 is unlikely to be involved in 
the ts1-mediated astrocytic cell death. Instead, p53 phosphorylation was increased by the 
early ROS upregulation via ATM, the protein encoded by the ataxia-telangiectasia (A-T) 
mutated gene. The early upregulation of p53 delayed viral gene expression by suppressing 
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expression of the catalytic subunit of NADPH oxidase (NOX). We further demonstrated that 
the ROS upregulation induced by NOX activation plays an important role in establishing 
retroviral genome into the host. Inhibition of NOX decreased viral replication and delayed 
the onset of pathological symptoms in ts1-infected mice. These observations lead us to 
conclude that suppression of NOX not only prevents the establishment of the retrovirus but 
also decreases oxidative stress in the CNS. This study provides us with new perspectives 
on the retrovirus-host cell interaction and sheds light on retrovirus-induced 
neurodegeneration as a result of the astrocyte-neuron interaction. 
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Chapter I. Introduction 
 
1.1. Background and Significance 
        
       The retrovirus is a specific class of virus, which poses a major health hazard due to its 
ability to cause persistent infection of the host system through integration into the host 
genome. Overwhelming evidence has demonstrated that retroviral infection is associated 
with pathogenic diseases in many animal species including humans (1). Recent HIV studies 
emphasize retrovirus-mediated diseases, yet the role of retroviruses in disease progression 
is still unclear. More importantly, retroviruses act not only as oncogenic or cytopathic agents 
but also as highly conserved endogenous genes in the DNA of many different species (1). 
This suggests that retroviruses are multifaceted agents with the ability to modulate cellular 
signaling pathways in the host cell.  
       Many morphological characteristics and many pathological and biological features of 
retroviruses are shared across subfamilies. Studies with human retroviruses are very 
limited due to the lack of appropriate tissue models, resulting in relatively slow progress. 
Instead, a considerable amount of information about the biological features of retroviruses 
has become available from animal models of retroviruses. In particular, murine retroviruses 
provide useful models for neuropathology of retroviruses because variation in virus strains 
as well as the age and strain of mouse models studied provide significant insights into the 
pathogenic mechanisms of the virus (2). Virus-host cell interaction can lead to various 
biological manifestations depending on host cell type and characteristics of the retrovirus. 
We believe that the most promising, rapid, and relatively safe approach toward acquiring 
knowledge of human disease associated with retroviruses would be obtained by the study 
of neuropathogenic retroviruses in murine models.  We also believe that research on 
retrovirus-induced diseases should be broadened from a basic understanding of virus-host 
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cell interaction toward a better understanding of cellular communication in a tissue-specific 
manner. Together, knowledge about the interaction of virus, host cells, and infected 
neighboring cells will provide perspective on pathogenic mechanisms and physiological 
disease progression in vivo. Throughout our study on the murine retrovirus-associated 
neurological disease, we have utilized a murine model infected with ts1, a neurovirulent 
mutant of moloney murine leukemia (MoMuLV), isolated from nonneurovirulent parental 
wild type MoMuLV-TB (3). ts1 infection of astrocytes and the events that follow play crucial 
roles in the ts1-induced neuropathogenesis (4). This Chapter is divided into four parts.  The 
first part will illustrate general features of retrovirus and our model of ts1. ts1 infection has 
been shown to be associated with the dysregulation of cellular ROS homeostasis (5). The 
second part will be devoted to current perspectives on intracellular ROS regulation and the 
challenge of oxidative stress in ts1-infected cells. Our study is focused on astrocytes 
because redox environment in the CNS is regulated by astrocytes (6). In the third part, the 
influence of ts1-infected astrocytes on neighboring neurons will be discussed. The final part 
will give a brief overview of the project. 
 
1. 2. General features of retrovirus and a neuropathogenic mutant of MoMuLV, ts1 
 
1.2.1. General features of retroviruses 
       In order to understand the biological features of retroviruses, it is essential to acquire 
knowledge of their structure and life cycle.  Shortly after the discovery of Rous sarcoma 
virus (RSV), the RNA virus was established as one of the etiological causes of the tumor 
(7). However, the early years of molecular biology presumed the “central dogma” in the viral 
replication process, which represents irreversible flow of genetic information from DNA to 
RNA to protein. In 1970, Howard Temin hypothesized that RNA tumor virus might have the 
ability to generate DNA from its RNA genome (8). The discovery of reverse transcriptase 
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(RNA-dependent DNA polymerase) added a new paradigm in replicating genomic materials 
(9). The RNA tumor virus was then renamed to retrovirus.  Reverse transcriptase allows 
single strand retroviral RNA genome to be reverse transcribed into double strand DNA, 
which integrates into the host chromosome. All retroviruses have a central core containing 
a diploid single strand RNA genome composed of three major open reading frames that 
encode polyproteins, Gag, Pol and Env, which are cleaved proteolytically to generate the 
functional viron components. Gag proteins are cleaved to form the internal viron protein 
components including the matrix, the capsid, and nucleoprotein. The Pol polyproteins are 
cleaved into reverse transcriptase, integrase, RNAase H and protease, and Env precursor 
polyproteins are processed into surface proteins and transmembrane proteins composed of 
viral envelope (Figure 1.1).  
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Figure 1.1 Diagram of retrovirus genome, gene products (polyproteins), and virus 
particle. MA-matrix, CA-capsid, NC-nuclear capsid, Pr-protease, RT-reverse transcriptase, 
SU-surface protein, TM-transmembrane protein, Int-Integrase. 
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       In the early years of retrovirus investigation, retroviruses were divided into three 
subfamilies: 1) oncoretrovirus, including all the oncogenic members and many closely 
related nononcogenic viruses; 2) lentivirus, the ‘slow’ replicating viruses, such as visna 
virus and human immunodeficiency virus; and 3) spumaviruse, the foamy viruses that 
induces cell death without any clinical diseases (1).  Current knowledge has now been 
expanded into seven genera: alpha-beta-, gamma-, delta-, epsilon-retrovirus, lentivirus and 
spumavirus. Retroviruses are categorized into these groups by distinctive biological 
features including morphology, site of assembly of the core, and presence of accessory 
genes, as well as degree of nucleotide sequence similarity in reverse transcriptases (Table 
1) (10). Simple retroviruses (alpha-, beta-, gamma-, delta-, epsilon-retrovirus) usually carry 
only this elementary information, whereas complex retroviruses (lentiviruses and 
spumaviruses) code for additional regulatory nonvirion proteins by producing alternative 
spliced products (11). 
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Subfamilia 
 
Genus Genome Distinctive features  Example 
Orthoretrovirinae Alpha-
retrovirus 
Simple Smaller genome (<8kb), 
wide spread in avian 
species, round 
morphology  
assembly at the plasma 
membrane 
 
Avian 
leukosis 
virus,  
RSV 
 Beta-
retrovirus  
(B or D type) 
Simple Intracytoplasmic 
assembly,  
after budding, core 
maturation occurs  
 
 
Mouse 
mammary 
tumor virus 
Mason-Pfizer 
monkey virus 
 
 Gamma-
retrovirus 
Simple Most oncornaviruses,  
Assembly at the plasma 
membrane 
 
MoLuLV 
 Delta-
retrovirus 
(c-type) 
Complex 
 
Assembly at the plasma 
membrane, contain genes 
tax and rex 
 
Human T-cell 
leukemia 
virus,  
 
 Epsilon- 
retrovirus 
 
Simple Contains orfs, A, B, and 
C. orfA is a viral homolog 
of cyclin D 
 
Walley 
dermal 
sarcoma 
virus 
 
 Lentiviruses Complex  
 
Long latency,  
Infectable non-dividing 
cells, 
Contain auxillary genes  
 
HIV, Visna-
maedi,  
Spumaretrovirina
e 
Spumaviruses Complex 
 
Prominent spikes on the 
surface, contain tas and 
bel gene 
forms large vacuoles in 
the host cells, no 
apparent disease 
association 
 
Human 
foamy virus 
 
Table 1. Classification of retrovirus. Retrovirus familia is composed of seven genera, 
alpha-, beta, gamma, delta, epsilon-retrovirus, lentivirus, and spumavirus. Their distinctive 
features and some examples are listed.  
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1.2.2. Infection, replication, and neuropathogenesis of retrovirus  
       Retrovirus infection in host cells affects the entire spectrum of cell fate from 
proliferation to cell death. The relationship between the status of target cells and retroviral 
replication has important implications, not only for the basic life cycle of retroviruses in the 
infected host cells, but also for our understanding of systemic pathogenesis caused by 
retrovirus-infected cells directly or indirectly. Most retroviruses in the host cells rarely induce 
cytopathic effects. These cells can serve as productive factories of virus progeny. After 
infection virus remains present in the cell, but often its expression of RNA or protein is 
undetectably low or suppressed. This enables the virus-infected cells to escape 
immunosurveillance. This latency is a particular characteristic of lentivirus and spumavirus 
infections (1). It has been shown that productive retroviral replication is determined by 
intracellular milieu of the host cells. For instance, the mouse ectoropic virus introduced into 
human cells via the xenotropic virus envelope replicates much less than it does in mouse 
cells (12). The dependence of retroviral replication on host cell proliferation or differentiation 
is also a commonality, although some retroviruses are able to infect non-dividing cells at 
greatly reduced efficiencies (13). Infection by some retroviruses, however, can lead to cell 
death. This is a particularly important element of lentiviral infections. Both direct and indirect 
cytopathic effects from the viral proteins have been proposed. Virons in the host cells may 
hijack host resources to replicate themselves. As a result, depletion of cellular resources 
may induce host cell death. Viral proteins at the host surface may also elicit cell-mediated 
destruction of the infected cells by the host’s own immunological response. However, the 
etiology of the retrovirus-mediated pathogenesis in vivo system appears to be more 
complex. For example, direct CD4-T cell death predominates when immortalized T cell lines 
are infected with laboratory-adapted human immunodeficiency virus -1 strains in culture 
(14). Conversely, in vivo physiological systems, infection of lymphoid tissue with HIV-1, the 
majority of dying cells appear to be uninfected ‘‘bystander’’ T cells (14, 15, 16), suggesting 
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that cytopathic effects of the virus are not necessarily limited to the infected cells. Viral 
infection may affect cell-to-cell communication leading to disruption of normal cellular 
functions (17). As a consequence, either infected cells or nearby cells may die. This 
bystander effect appears as a main cause of neuronal cell death in retrovirus-induced 
neurological diseases (18).  
       A number of retroviruses are associated with neurological and systemic disorders. Viral 
invasion of the nervous system and the development of neurological symptoms are 
characteristics of many retroviruses, including the murine leukemia viruses (MuLV), and 
HIV-1 (19), as well as human endogenous retroviruses (20). A recently identified retrovirus, 
called xenotropic MuLV-related virus, is also linked to chronic fatigue syndrome in humans, 
but this remains controversial (21). With the appearance of HIV, which can also cause 
disease in the nervous system, investigation of the pathogenesis of neurological problems 
induced by retroviruses has become highlighted. In spite of many years of study, much is 
still poorly understood about the mechanisms that underlie retrovirus-induced 
neuropathogenesis. Retrovirus-mediated neurodegeneration in the CNS possibly evolved in 
two separate events: Invasion of retrovirus in the CNS cells, and exerting cytopathic effects 
on neurons. Neurovirulent retrovirus must penetrate the blood brain barrier (BBB) either as 
free virus or within infected cells to gain access into the nervous system. Some neurotropic 
viruses, like herpes simplex and rabies virus, enter the CNS by retrograde axonal transport 
following peripheral infection of nerve endings. Lentiviruses penetrate the CNS via infected 
immune cells or endothelial cells. Although there have been more intensive studies 
focusing on HIV-infected immune cells as a virus carrier to the CNS, some 
immunohistochemical studies have demonstrated HIV infection of capillary endothelial cells 
in the brain (22), which may produce progeny virus into abluminal space. It is also 
noteworthy that infection of endothelial cells typically occurs in the absence of morphologic 
or functional defect (23). The area with infected CNS endothelial cell does not necessarily 
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determine the site of neuropathology, which occurs in a later period in the course of the 
disease (24). The relationship between viral load and disease progression in the CNS is 
much less clear. Although HIV is detectable in the CNS, the viral load does not necessarily 
reflect the incidence of HIV-mediated neuronal death because retroviruses do not replicate 
in neurons. The most perplexing and intriguing question in retrovirus-mediated 
neuropathogenesis is which cell type plays a crucial role in neuronal death. Highly 
neuroactive antiretroviral therapies (HAART), which target replicating virus, offer only partial 
clinical benefit to patients with HIV associated dementia, suggesting that neuronal death in 
retrovirus-infected CNS may not directly associated with productive viral replication (2, 25). 
 
1.2.3. The ts1 mouse model, a model of retrovirus-induced neurodegenerative 
diseases.  
       Some mutant murine retroviruses, including ts1 and FrCasNC (derived from the CasBrE 
retrovirus) cause spongiform encephalopathy in infected mice whereas their parental wild 
type retroviruses do not cause neurovirulent pathogenesis (26, 27). For many years, our 
research has focused on a murine model of retroviral-induced CNS disorders. Our model 
utilized several temperature-sensitive mutants of MoMuLV. One of these mutants, 
designated ts1, has been studied most extensively (28). Although ts1 was isolated originally 
from spontaneous temperature-sensitive mutants (29), temperature sensitivity per se is not 
necessarily an essential property for neurologic disease induction (30). The neurovirulent 
symptoms of ts1 infection in mice compared to nonneurovirulent parental virus appear to be 
caused by misfolded viral envelope proteins (3). The newly synthesized envelope precursor 
polyprotein gPr80env begins to process soon after biosynthesis and forms trimers in the 
endoplasmic reticulum (ER) (31). At the restrictive temperature (39oC), the gPr80env is 
unable to fold properly due to a single amino acid substitution Val-25->Ile in gPr80env, and 
accumulated in the ER instead of trafficking to the Golgi apparatus and plasma membrane 
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by chaperones (Figure 1.2) (32). As a consequence, gPr80env is inefficiently processed into 
gp70 (surface protein) and Prp15E (precursor of transmembrane protein). Since the 
neurovirulent mutants are derived from known, nonparalytogenic parental viruses, the exact 
gene or gene sequence that confers the ability to induce paralysis can be elucidated. The 
neurovirulent property of the gene sequences of the mutants should help to gain insight into 
the molecular mechanisms of the pathogenesis of neurologic diseases.  Another benefit of 
the ts1 system is that ts1-inoculation of susceptible strain of mice (FVB/N) show a 
predictable histopathologic profile. FVB/N mice infected with ts1 shortly after birth develop 
lesions and a mild, generalized body tremor appearing about 20 days post inoculation. This 
progresses to hind-limb paralysis within 25-30 days. The mice also exhibit severe 
retardation in growth, body wasting, and thymic atrophy that correlates with depletion of 
circulating T cells (33). The the latency period depends on the relative amount of virus and 
the age of mice when the virus is inoculated (30). Induction of the disease is correlated with 
the appearance of a spongiform encephalomyelopathy with no inflammatory response by 
peripheral immune cells. The severe spongiform lesions and reactive gliosis manifest in the 
brain stem and lumbar spinal cord. Vacuolization is observed in neurons and neighboring 
glial cells in the brain stem, and ventral horns of the spinal cord. Histological findings 
confirmed that the neurologic signs of paralysis were caused by lower motor neuron 
degeneration in ts1-infected mice. Lateral and vertical funiculi had generalized symmetric 
spongiform changes and in some instances, lesions appeared in the gray and white matter 
as well as at the gray/white matter junction. The distribution of spongiform changes in the 
CNS of ts1-infected mice suggest that major involvement of upper motor neurons of the 
extrapyramidal system also occurred in addition to involvement of lower motor neurons 
(34).  
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Figure 1.2. ts1 envelope protein processing from biosynthesis, folding, trimerization 
and transport to the Golgi apparatus. The single amino acid substitution of Val25->Ile 
does not prevent oligomerization of monomers. However, due to improper folding, the 
structure of the oligomer renders it defective in transport from the ER to the Golgi 
apparatus. As a consequence, gPr80env accumulates in the ER.  
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        ts1 has cell type-specific cytopathic effects, by which it causes neurodegeneration and 
immunodeficiency through infection of the cells in the CNS and in T-lineage lymphoid cells 
(30). The result is a disease that resembles HIV infection in several important ways (19, 
35). The characteristic features of both HIV- and ts1-induced diseases are T cell depletion 
(35, 36), and cell death in astrocytes and neurons in the CNS (19, 37, 38, 39, 40). T cells 
and macrophages are primary peripheral targets for both HIV and ts1 (33,	  41). In the CNS, 
both HIV and ts1 infect microglia, astrocytes, and endothelial cells, but not neurons (33, 42, 
43, 44, 45). ts1-induced neurodegenerative disease (ND) is possibly recapitulating many 
clinical and pathological features of HAD, suggesting that important similarities exist 
between ts1-induced ND and HAD. Moreover, one of the phenomenal advantages of using 
ts1 to study retrovirus-mediated ND is that the progression of pathogenesis is highly 
reproducible. There is little variation within the visually detectable stages of pathogenesis 
and a high mortality in ts1-infected mice. The relatively short and predictable time period to 
produce neuropathogenic symptoms makes the ts1 model an excellent tool to identify many 
aspects of pathogenesis in retrovirus-induced ND.  
 
1.3. Current perspectives on intracellular ROS regulation and oxidative challenge in 
ts1-infected astrocytes 
 
1.3.1. ROS, a constant challenge in homeostasis of cellular environment  
       ROS are a class of oxygen containing molecules that react with cellular 
macromoleucles, including proteins, lipids, and nucleic acids. Understandably, ROS levels 
are tightly regulated to avoid dysregulation of signaling pathways and damage in cells. 
Depending on its concentration, location, and context, ROS may be either beneficial or 
detrimental to cells. For a long time, mitochondria have been considered as the major 
source of intracellular ROS. The electrons from nicotinamide adenine dinucleotide 
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phosphate (NADPH) and 1,5-dihydro-flavin adenin dinucleotide (FADH2) transfer to oxygen 
(O2) via serial electron transfer chains in mitochondria to generate cellular energy, 
adenosine triphosphate (ATP). However, the stepwise respiratory chains are not 
thermodynamically perfect machines.  Some electrons escape from the electron transfer 
chain and react with O2 producing superoxide (O2-) as a consequence (46). In quiescent 
cells quantal burst of O2- production has been reported. This O2- burst is observed in a wide 
range of cell types including neurons and muscles at different frequencies (47). The other 
possible depository for intracellular ROS is the ER. Newly synthesized proteins need to fold 
properly in order to be delivered to the destined intracellular location.  The ER provides an 
oxidative environment that is conducive for disulfide bond formation. During disulfide bond 
formation in nascent protein, oxidants are produced as a result of electron transport from 
SH-groups in the cysteine residues of the protein. Reduced (GSH) and oxidized glutathione 
(GSSG) in the ER lumen participate in catalysis of protein disulfide isomerase (PDI) and ER 
oxidoreductase 1(Ero1) redox (Figure 1.3). In this context, it is not surprising that 
inappropriate disulfide bond formation or breakage occurs when thiol redox potentials are 
disturbed. These conditions cause protein misfolding and exacerbate oxidative stress in the 
cell, leading to release of Ca2+ from ER stores. The excess Ca2+ is taken up into the inner 
membranes of the mitochondria, thereby disrupting the electron transport chain. This 
diverts the electrons off-course and allows their release from the mitochondria and reaction 
with O2 in the cytoplasm, producing ROS. The ROS produced during these events can 
cause further Ca2+ release from the ER, resulting in amplified accumulation of ROS, at toxic 
levels leading to cell death (48, 49). Thus, oxidative stress, ER stress and mitochondrial 
impairment are intimately linked (50, 51). It is noteworthy that pathogenesis in 
neurodegenerative diseases share common mechanisms involving oxidative stress 
although they may have diverse causes. Retrovirus-mediated oxidative stress may involve 
all these sources of ROS. Another O2- -generating source is respiratory bursts in 
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phagocytes. NADPH oxidase (NOX) in phagocytic cells transfers singlet electrons to O2 to 
produce O2- (52). NOX was first studied in phagocytic cells but recent studies have shown 
that NOX subunits are also present in non-phagocytic cells including neurons and 
astrocytes (53, 54). 
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Figure 1.3. Cellular ROS sources. Mitochondria. Some electrons escape from the electron 
transfer chain in the mitochondria and produce O2-. ER. Oxidative environment in the ER 
produces oxidants during formation and correction of disulfide bond. NOX. NOX located on 
the membrane transfer an electron to O2 generating O2-. Short-live O2- is a precursor to 
other ROS and is dismutated to H2O2. O2- can react with limited chemical targets as an 
oxidant whereas H2O2 acts as a more prevalent oxidant targeting cysteine residues in 
enzyme active sites.
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       As mentioned above, ROS are constantly produced during normal metabolism. It is 
natural that cells engage in a variety of ways to regulate or modulate ROS levels to 
maintain intracellular redox balance to control cell fate. One good example is the 
antioxidant defense system involving p53. While p53 is linked to pro-apoptotic processes, 
expression of p53 drives a number of antioxidant responses that can limit accumulation of 
ROS. p53 induces antioxidant genes including glutathione peroxidase 1(GPX1), 
manganese superoxide dismutase (MnSOD), and aldehyde dehydrogenase 4 family 
(ALDH4) (55). The diversion of glucose-6-phosphate into the oxidative pentose phosphate 
pathway (PPP) by a p53-dependent factor, TP53-induced glycolysis and apoptosis 
regulator (TIGAR), produces NADPH that reduces GSSG to GSH (56). p53-dependent 
glutaminase 2 (GLS2) expression upregulates the production of the GSH precursor 
glutamate (57, 58). The sestrins, a family of stress-responsive proteins involved in the 
regulation of ROS, are also induced by p53 (59). The importance of antioxidant activity of 
p53 is further supported by antioxidant treatment of p53 knockout mice. The absence of 
p53 leads to imbalance of cellular metabolism that has lower mitochondrial oxidative 
phosphorylation. p53 knockout mice often develop spontaneous lymphoma, which is 
prevented by antioxidant treatment (55).  
 
1.3.2. ROS as messenger molecules in cells 
       ROS can elicit a wide range of cellular responses (Figure 1.4). For many years, ROS 
have been viewed as harmful molecules that damage cellular macromolecules.  Recent 
studies showed that low levels of ROS often modulate normal intracellular signaling 
pathways. Interestingly, ROS produced in non-immune tissues oxidize a more limited 
spectrum of target molecules, and these specific oxidations can be used for particular 
biological functions rather than producing widespread molecular damage (56, 60).  
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Figure 1.4. Different levels of intracellular ROS and cell fates. Low levels of ROS can 
induce cell proliferation. Moderate levels of ROS cause temporary or permanent growth 
arrest, resulting in cellular differentiation or senescence. High levels of ROS can cause 
cellular apoptosis. 
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       As noted before, ROS generated by normal cellular processes in the mitochondria and 
ER are unintentional byproducts. However, cells also produce ROS intentionally. 
Phagocytic cells engulf foreign microorganisms and produce O2- by NOX to destroy them. 
The reactivity of individual ROS differs greatly. O2- is a precursor to other ROS and is 
dismutated to hydrogen peroxide (H2O2) either by superoxide dismutase (SOD) or 
spontaneously in low pH. O2- can react with limited chemical targets as an oxidant whereas 
H2O2 acts as a more prevalent oxidant targeting cysteine residues in enzyme active sites 
(61). H2O2 is further decomposed into innocuous H2O and gaseous O2 by catalase. H2O2 is 
also involved in the oxidation of cysteine residues on proteins, which may affect enzyme 
activity (62). Upon cell attachment to the extracellular matrix or receptor binding to its 
ligand, the tyrosine kinase becomes oxidized by H2O2 at cysteine residues and thus 
activated. On the other hand, tyrosine phosphatase becomes inactivated when it is oxidized 
by H2O2 at cysteine residues (63). In this case, ROS, mainly H2O2, serve as a messenger 
molecule for the modification of signaling proteins. The concentration and location of ROS 
must be carefully controlled by specific ROS detoxifying enzymes in the cells. Given the 
reactivity of ROS, spatial and temporal regulatory strategies must be present to ensure that 
a specific kind of ROS upregulation occurs only where it is desirable and that the ROS 
signal is terminated in a timely manner. Whereas catalase is confined to the peroxisome, 
several peroxiredoxin isoforms exist in the cytoplasm (64). H2O2 must be sheltered from 
destruction by peroxiredoxin in selected contexts. The advantage of intracellular vesicles is 
that they can have distinct ROS levels separate from the cytoplasm. Indeed, they have very 
different and highly specialized functions. For example, a subgroup of early endosomes 
contains NOX (65, 66). These vesicles, termed “signaling endosomes” (66) or 
“redoxosomes” (67), function in the processing of endocytosed proteins. O2 from the 
extracellular space is secluded in the lumen of early endosomes and converted into O2- by 
the NOX accepting electron from NADPH.  The primary function of endosomes may be to 
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provide the limited area for signaling process mediated by ROS upregulation. It is also 
possible that NOX-dependent generation of ROS in endosomes may also be relevant to 
other subcellular locations in which the NOX is activated (68). The highly reactive 
environment of the endosome lumen may play an important role in the activation of the pre-
integration complex of invaded retroviruses (69). After fusion of the viral envelope with the 
plasma membrane, the viral preintegration complex is released into the cytoplasm. At this 
point, the viral reverse transcriptase has to be activated. It is possible that ROS in early 
endosomes may catalyze viral protein activation. The relevant oxidation targets for viral 
activation that are presumably enriched in these microenvironments must be identified. 
 
1.3.3. ROS may play important roles in life cycle of retrovirus 
              The life cycle of the retrovirus can be generally divided into two distinct phases. An 
early phase refers to the binding of virions to the cell surface through the integration of viral 
DNA into the host genome (pre-integration phase). A late phase includes the transcription 
and translation of the provirus through the assembly of all viral components at the plasma 
membrane and release of progeny virons, followed by a maturation process of the virus 
outside of the cell (post-integration phase) (70) (Figure 1.5). ROS may play important roles 
in both phases of retrovirus life cycle. In the early phase, viral pre-integration complex 
reinforces reverse transcriptase activity to generate viral DNA from genomic RNA and 
transport the viral DNA into the host nucleus. During this early phase, low levels of ROS 
upregulation may activate the host cells either to enhance viral DNA synthesis (71) or the 
DNA integration process to establish a viral gene in the host cells. In the late phase, after 
viral establishment in the host genome, viral replication, initiated by transcription and 
translation of viral genes, appears to be more favorable if the cells are in a more 
proliferative state. For example, following the entry of the retrovirus, the vast majority of the 
viruses may not successfully establish themselves as an integrated provirus (70). 
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Moreover, the integrated provirus may have limited opportunity to replicate depending on 
the microenvironmental status of the cell. The intracellular environment plays an important 
role in retrovirus replication (72). Retrovirus-infected cells can produce progeny virus 
productively or restrictedly (73, 74). Productively infected cells support viral replication and 
participate in the transmission of the infection. Astrocyte infection by HIV-1 in the CNS is 
generally known to have restricted viral replication (74). In these restrictive cells, efficient 
viral replication might be blocked at different phases of the life cycle of retrovirus, including 
reverse transcription, viral gene integration in the cells, expression of the provirus and 
assembly, as well as release of progeny viral particles. These cells are able to restrict viral 
replication and survive. However, they may act as a virus reservoir in which a replication-
competent viral genome persists. For instance, cells are permissive to infection by 
retrovirus and they could be refractory to efficient viral expression. Virus production in 
chronically infected cells can be transiently activated by cytokines (75, 76). In the same 
context, the quiescent environment of the CNS may pose an obstacle in retrovirus 
replication and ROS may play an important role in promoting productive viral replication. 
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Figure 1.5. Retrovirus life cycle. The life cycle of the retrovirus is arbitrarily divided into 
two phases: the pre-integration and post-integration phases. The pre-integration phase 
involved from binding of virons to the cell surface through the integration of viral DNA into 
the host genome. The post-integration phase consist of the transcription and translation of 
the provirus through the assembly of viral components at the plasma membrane and 
release of progeny virons. A maturation process of MoMuLV occurs outside of the cell. 
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       ROS generated in some nonphagocytic cells are involved in mitogenic signaling. As 
mentioned above, ROS and its signaling effects at low physiologic levels play a role in 
mitogenic effect in many cells types (77). Many cancer cells show increased production of 
ROS (78), while normal cells exposed to H2O2 show increased proliferation (79) and 
express growth related genes (80). ROS producing enzymes, such as NOX, have been 
described to be activated by mitogenic stimuli (81). ROS have been shown to induce and 
maintain G1 phase cyclin D1 expression in mouse lung epithelial cells (82). Similarly, 
Havens et al have shown that ROS levels are increased in a cell cycle–dependent manner 
and oscillated with every cell division in human T98G glioblastoma cells, human leukemic T 
cells, and NIH 3T3 cells (83). Although they did not identify the source of ROS in these 
cells, ROS upregulation appears to play an important role in cell cycle because the 
proliferative cells undergo transient arrest and fail to progress from G1 to S phase during 
treatment with various antioxidants (84, 85, 86). Although many of the mechanisms of 
cyclins in entrance and progression of G1 phase have been widely explored, ROS have 
been more recently shown to be important for the expression of G1 phase cyclins (82, 83, 
86, 87, 88). Consequently, the commitment of the cell to division is critical to achieve 
retrovirus replication (89). This notion is supported by a number of studies showing that 
productive retroviral infection requires cell activation (90). For instance, cell cycle 
progression and viral replication in cells may be efficiently suppressed with the use of 
cyclin-dependent kinase inhibitors (91). However, up until this point it had not been 
established whether the entry of retroviruses into the cell could promote action of the 
proliferative signaling pathway. It has been reported that HIV-1 gene expression is 
markedly increased by progression of the cell cycle beyond the G1-S phase checkpoint	  
(92). Low levels of ROS upregulation by viral infection may promote productive virus 
infection. It is noteworthy that not all ts1-infected astrocytes die. Previously Qiang et al have 
investigated surviving cells from chronic ts1-infection. To determine how these resistant 
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cells survive ts1 infection in culture, they established and characterized a subline of these 
cells (C1-ts1-S). C1-ts1-S cells proliferate slower and produce fewer viruses than C1 cells. 
This is associated with their antioxidant defense responses. For example, they show lower 
levels of H2O2, increased uptake of cystine, and higher levels of GSH and cysteine, 
compared to those in acutely infected cells or to those in uninfected cells (93).  This 
suggests that C1-ts1-S cells upregulate their thiol defenses in order to survive, and by 
doing so, virus replication in C1-ts1-S decreased.  
       A previous study in our laboratory has also shown ROS upregulation in ts1-infected 
astrocytes and that antioxidant treatment significantly delays ts1-induced 
neurodegeneration. It also demonstrated that enhanced antioxidant defense does not 
remove the retrovirus, yet it does significantly decrease viral replication significantly in the 
infected host by delayed antioxidant treatment in ts1-infected mice (94). Taken together, 
ROS upregulation appears to be involved in two separate steps in retrovirus-infected cells. 
First, ROS upregulation increases viral replication in the host cells. The notion that ROS 
may play a role in cell proliferation is supported by the proliferative characteristics of cancer 
cells coinciding with higher ROS levels (55). To promote viral replication, the retrovirus may 
posses a mechanism to increase intracellular ROS levels. In particular, ts1 may have to 
change the quiescent microenvironment of the CNS to a more proliferative environment to 
replicate progeny viron productively by upregulating ROS. At 30 days post-infection, 
neurovirulent ts1 titer in brain tissues is higher than non-neurovirulent WT virus. Second, 
excess ROS upregulation can induce cell death by causing oxidative stress, which has 
been well documented previously (95).  
 
1.4. Astrocytes may play important roles in retrovirus-mediated neuropathogenesis  
 
1.4.1. Cell types in the CNS infected by retroviruses. 
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       Some retroviruses are known to cause neurological diseases, but the pathogenic 
mechanisms remain poorly understood. Although the viral envelope protein has been 
shown to be crucial in the pathogenesis of these NDs, the mechanisms underlying neuronal 
death in these diseases are unclear. Neuropathological features show no detectable 
peripheral inflammatory cell infiltration in the brain of ts1-infected mice. The most 
controversial question is whether neuronal cell death is the direct result of viral infection or 
the indirect result of glial cell infection. Despite the fact that the loss of motor neurons is the 
cause of MuLV-mediated neurologic diseases, replication of MuLV is known to occur only in 
mitotic cells (90). Capillary endothelial cells and pericytes are the most conspicuously 
infected cell type by all the neuropathogenic MuLVs. In spite of the observation that 
endothelial cells are highly supportive of neuropathogenic MuLV replication, infected 
endothelial cells are not likely to be directly associated with neuronal cell death. Endothelial 
cell infection is widespread and not restricted to the location of spongiform lesions (42). 
Furthermore, morphological or functional changes are not observed from the capillary 
endothelial cells in the PVC-211-infected CNS (96). The CNS is composed of neurons and 
glial cells. Neurons are the main cell type involved in motor and cognitive function, and glial 
cells support the neurons. Glial cells can be divided into four different cell types: ependymal 
cells, microglia, oligodendrocytes, and astrocytes (97). Ependymal cells line the 
cerebrospinal fluid (CSF)-filled ventricles in the brain and central canal of spinal cord. 
These cells possess microvilli, which is believed to be involved in the directional movement 
of CSF. The fact that the location of ependymal cells correspond to the fourth ventricle area 
with high ts1 titer may indicate that retrovirus may gain access to the CNS via CSF (98). 
However, whether ependymal cells are infected by retrovirus is not known. Microglia are 
derived from macrophages, which migrate to the CNS during development (99). This is 
another cell type that expresses neuropathogenic MuLVs in infected mouse CNS. However, 
whether microglia are infected by neuropathogenic MuLVs is in debate because CasBrE-
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virus antigens are not detected in the infected microglia in the CNS (100).  Although the 
presence of neuropathic MuLV particles was detected in microglia in the CNS, this may 
reflect phagocytosis of virus–infected cells and virons in the infected regions of the CNS. 
Oligodendrocytes produce a myelin membrane that surrounds axon to promote axonal 
conduction. Due to the difficulty in identifying oligodendrocytes in the CNS, the ability of 
MuLVs to infect oligodendrocytes is ambiguous. Although ts1 was found at the surface of 
oligodendrocytes (98), whether their infection actively participates in neuronal death also 
remains unclear.  Astrocytes provide a functional and physical link between endothelial 
cells to neurons by transporting nutrients and maintaining the integrity of Blood-brain-barrier 
(BBB) (Figure 1.6). In vivo studies suggest that perivascular astrocytes foot processes are 
the first structures to exhibit vacuolar changes. Vacuolization is the prominent 
histopathologic feature shared by neuropatholgic MuLVs.  As the disease progresses, 
vacuoles increase in size and number in the areas of the spongiform lesion. Several reports 
also indicated that HIV can directly infect and replicate in cultured astrocytes (101, 102, 
103, 104). The expression of HIV-1 gp120 in astrocytes induces neuropathologic alteration 
in the mouse CNS (98, 105). In the CNS, astrocytes comprise more than 50% of total cells 
(106) and they have crucial homeostatic and redox regulatory functions that maintain 
neuron integrity (107). Extracellular GSH is metabolized into gamma glutamyl-dipeptide 
amino acid and cysteinylglycine, which are then broken down to cysteine and glycine. 
Cysteine is used for neuronal GSH synthesis after transported by the EAAC1 transporter 
(108). The intimate association between astrocytes and neurons and the role of astrocytes 
in regulating the neuronal environment suggests that neuronal degeneration appears as a 
secondary effect of retrovirus-infected astrocytes (30). It is also possible that a functional 
interplay between macrophages, endothelial cells and astrocytes might contribute to 
retrovirus-induced neuropathogenesis. Proteomic modeling of HIV-1 infected cells, in a 
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study of astrocyte-microglia interactions, has shown that astrocytes have a profound effect 
on protein expression in HIV-infected microglia (109).  
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Figure 1.6. Astrocytic neuronal support in the CNS 
Astrocytes play an important role in maintaining the microenvironment of neurons. Delivery 
of nutrients from capillary endothelial cells to neurons as well as maintenance of the 
integrity of BBB is a responsibility of astrocytes. Astrocytes also are crucial in providing a 
homeostatic environment by supplying cysteine and recycling neurotransmitters. Astrocytes 
supply the GSH precursor, cysteine. Glutamate, when released during synaptic 
transmission, is quickly reabsorbed and converted to glutamine by astrocytes and delivered 
back to the presynpatic neurons. 
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1.4.2. Astrocytes may play an important role in ts1-mediated neuropathogenesis 
       One puzzling aspect of ts1-mediated ND is the consequence of cell type-specific 
response after ts1 infection. We speculate that the etiology of ts1-induced 
neurodegeneration underlies this cell type-specific response. ts1 seems to infect all cell 
types in the CNS except neurons. The cell type that replicates ts1 most productively within 
the ts1-infected CNS appears to be the endothelial cell type (42). However, ts1 replication 
in capillary endothelial cells does not lead to morphological changes whereas astrocytes at 
the infected region show intracellular vacuolization. Progeny ts1 produced by endothelial 
cells may penetrate into astrocytes due to their physical location. ts1 infects astrocytes in 
the mouse CNS although the astrocytes may not replicate progeny viruses productively in 
the CNS. In Chapter 2, we demonstrate that ROS upregulation occurs before productive 
virus replication. ROS upregulation in ts1-infected astrocytes can cause thiol deficiency in 
neurons. Infected astrocytes may fail to provide GSH as antioxidative defense to their 
adjacent neurons. ROS upregulation in ts1-infected astrocytes may affect a wide range of 
other functions as well. For instance, ROS upregulation by ts1-infection can decrease 
glutamine synthase (GS) in the astrocytes (110). This results in failure of glutamate 
absorption by glial cells in close proximity, leading to neuronal death. Production of 
extracellular ROS from ts1-infected astrocytes may also induce oxidative stress in neurons 
and damage macromolecules of neurons. The subsequent release of viral proteins or toxic 
metabolites from ts1-infected astrocytes may then be harmful to neurons and result in 
amplification of neurodegenerative mechanisms as assumed in HIV-associated dementia 
(HAD) (111). As the disease progresses, apoptotic changes are seen in astrocytes and the 
adjacent neurons. These results indicate that neuronal loss induced by ts1 may not be due 
directly from the productive viral infection of neurons, but rather indirectly from the infected 
astrocytes.  
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1.5. Project overview  
       The causes of ND are complex, but recent studies demonstrate that oxidative stress 
plays an important role in these conditions (53, 112, 113). Previous studies in our laboratory 
have shown that ROS are upregulated in cultured ts1-infected astrocytes, and that 
antioxidant treatment delays neurodegeneration in ts1-infected mice (5, 94). However, 
despite the great potential benefit of antioxidant treatment as shown in several animal 
models, many of the antioxidant therapies tested to treat retrovirus-mediated 
neurodegenerative diseases in humans thus far have not been effective (114).  This is 
primarily because they are not inhibiting a validated therapeutic target or specific pathway. 
In this study using ts1-infected astrocyte model, we attempt to identify the interactions 
between retroviruses and the host cells in ROS regulation during the retrovirus life cycle. 
Throughout this study, we seek to define the early and late phases of ts1 life cycle in 
astrocytes within the context of fluctuating ROS levels. We hypothesize that ROS 
upregulation during the early phase of ts1 infection may activate astrocytes to replicate 
viron progeny productively. In Chapter 2, we demonstrate that ts1 infection of astrocytes 
increases levels of intracellular ROS in the early stage of infection, and that this 
upregulation is distinct from ROS upregulation during the later apoptotic phase. We provide 
evidence to support antioxidant activity of p53 in the early phase of ts1 infection. Although 
we initially hypothesize that p53 plays an important role in ts1-induced cellular apoptosis, 
we observe that the absence of p53 did not prevent either cell death in cell culture or the 
neuropathological symptoms in mice after ts1 infection. Instead, the early ROS upregulation 
appears to activate p53 via protein kinase ATM. Because the absence of p53 expression 
increases intracellular ROS levels, we speculate that p53 plays an important role in 
suppressing ts1-induced ROS upregulation. In addition, the expression of viral proteins 
after ts1 infection occurs earlier in p53-/- astrocytes than in p53+/+ cells, suggesting that 
retroviruses utilize the lack of p53-mediated antioxidants as a tool to facilitate early viral 
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establishment. We also observe that p53 downregulate the expression of a catalytic subunit 
of O2- producing enzyme NOX in ts1-infected primary astrocytes. From these observations, 
we conclude that p53 is unlikely to play a direct role in anti-viral defense. Rather, p53 
upregulation seems to provide an indirect cellular defense mechanism against the virus by 
modulating ROS levels. 
       Based on the observation that p53 downregulates NOX in ts1-infected astrocytes, we 
further hypothesize that NOX may play an important role in ROS upregulation in the early 
phase of ts1 infection. In Chapter 3, we show that NOX is activated in cultured ts1-infected 
astrocytes as well as in the CNS. The activation of NOX occurs during retroviral 
establishment in host cells, but not during cell death. These results suggest that NOX plays 
an important role in the enhancement of viral gene integration into host genome, but is not 
involved in the unfolded protein response caused by misfolded viral env protein.  As 
expected, the inhibition of NOX decreased viral replication, prevented ts1-induced cell 
death, and therefore, delayed onset of pathological symptoms in ts1-infected mice. These 
observations led us to conclude that the suppression of NOX in the early phase of viral life 
cycle can prevent the establishment of the retrovirus. Therefore, it helps host cells to win 
the battle against the virus instead of suppressing viral replication after viral establishment. 
The influence of retrovirus-infected astrocytes on the onset and progression of retrovirus-
induced ND gives us a new perspective on the importance of CNS astrocyte-neuron 
interactions and on further understanding of the pathogenic mechanisms underlying 
retrovirus-induced ND.  
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Chapter 2. ROS upregulation in the early phase of retrovirus infection  
and the role of p53 as an oxidative stress modulator 
 
2.1. Introduction 
 
       Oxidative stress occurs in cells when production of ROS exceeds antioxidant defenses 
(115). Cellular defense responses to oxidative stress occur in a controlled sequence. The 
first level of defense involves upregulation of SOD and catalase to counter ROS buildup. 
Uptake of cysteine is the rate-limiting step for intracellular GSH generation, suggesting that 
cysteine levels are important in cell proliferation. In an oxidative environment, extracellular 
cystine, which is formed by the oxidation of two cysteines, is imported into astrocytes in 
exchange for glutamate via cystine-glutamate antiporter (xCT), in turn reduced to cysteine. 
If ROS overload causes significant depletion of cysteine and GSH, the second line of 
defense is deployed via activation and nuclear translocation of the transcription factor NF-
E2 related factor 2, or Nrf2 (116). In the nucleus, Nrf2 binds to antioxidant-responsive 
elements (117), resulting in upregulation of the xCT to reduce cystine to cysteine. Once 
sufficient cysteine is present in the cellular environment, the modulatory subunit of glutamyl 
cysteine ligase inhibits GSH production via a negative feedback mechanism.  Previous 
studies in our laboratory have reported that ts1-infected astrocytes exhibit signs of oxidative 
stress, including lower intra- and extracellular cysteine and GSH levels compared to both 
uninfected and parental MoMuLV-TB WT-infected astrocytes. We suspected that the cell 
death process initiated by the accumulation of misfolded gPr80env might increase 
intracellular ROS levels (32).  Viral titer of ts1 progeny virus was lower than that of 
MoMuLV-WT at 24 hours post infection (hpi) in astrocytic culture (5). However, ts1 titer 
became higher than WT titer at 48 hpi. Coinciding with in vitro results, ts1 also had a higher 
titer than WT virus in mouse CNS at 20-30 days following inoculation, although the titer of 
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ts1 and WT were initially similar (5, 43). One explanation for this late increase in ts1 titer is 
that overwhelming ROS upregulation induces cell death in ts1-infected astrocytes and 
facilitates the breakdown of cell membrane. This allows the progeny virus to be quickly 
released from the host cells thereby disseminating viral progeny to nearby uninfected cells. 
Therefore, preventing ts1-mediated apoptosis process would be an important step in 
prevention of further virus propagation. We initially hypothesized that ts1-induced cell death 
may be mediated by p53. p53 induces ROS generation, which then causes disruption of 
mitochondrial membrane potential (118). p53 is a well-known transcription factor that 
induces pro-apoptotic gene expression.  Elevated p53 immunoreactivity has been detected 
in the animal brains of human neurodegenerative disease models and from patients with 
HAD (119, 120, 121). Similarly upregulation of p53, bax and p21 in the CNS has been 
shown in ts1-infected mice compared to uninfected mice (122). However, it is noteworthy 
that p53 immunoreactive astrocytes in the CNS lesions do not have the characteristic 
morphology of apoptotic cells seen in ts1-infected mice despite p53 upregulation (122). This 
observation suggests that ts1-mediated p53 upregulation in astrocytes may not necessarily 
lead to apoptosis. This prompted us to further investigate whether p53 plays a critical role in 
ts1-mediated cell death. Although p53’s role in apoptosis has been well-established, recent 
evidence indicates that p53 can sense a multitude of cellular stresses and orchestrate 
cellular signaling pathways. p53 may function as a survival factor by regulating intracellular 
ROS levels. In steady state conditions, cells maintain low levels of p53 that are sufficient for 
the cell-protective transcription of antioxidant genes to protect cells (55). p53 expression 
levels are more closely related to defend intracellular environment than to cause suicide as 
a consequence of cellular stress. For example, p53 protects DNA oxidation by regulating 
levels of cellular anti-oxidant factors, such as GSH or NADPH (56, 57, 58). Cells that 
express higher p53 level show a higher resistance to cell death caused by oxidative 
damage. Alternatively, suppression of p53 expression makes cells susceptible to H2O2 –
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mediated damage. Disruption of cellular ROS homeostasis in p53-depleted cells was also 
detected by increased intracellular H2O2 (123). 
       In this chapter, we demonstrate that ts1 infection causes two separate ROS 
upregulation events in host cells. The first occurs during early viral establishment in host 
cells and the second ROS increase occurs during the apoptotic process.  We examined 
whether p53 plays a crucial role in the initiation of apoptosis or in protection against 
oxidative stress in ts1-infected astrocytes. p53 functions as a modulator of intracellular ROS 
followed by the early phase of ROS upregulation in ts1-infected astrocytes. However, ts1-
mediated astrocytic apoptosis regulation is p53-independent.  
 
2.2. Materials and methods 
 
2.2.1. Mice 
       p53+/- FVB/N mice were given as generous gifts from Dr. David Johnson (The 
University of Texas M.D.Anderson Cancer Center). Offstprings were genotyped by 
polymerase chain reaction (PCR)-based assays of mouse tail DNA. For ts1 infection 2-day-
old mice were inoculated intraperitoneally with 0.1ml of vehicle (uninfected control) or with 
0.1ml of ts1 virus suspension containing 2 x 107 infectious units (IU)/ml. For mice given this 
dose of ts1, early stages of paralysis were evident by approximately 30 dpi. We 
differentiated disease progression into four stages (stage I, hindlimb drop; stage II, tremor; 
stage III, loss of mobility; stage IV, paralysis), and sacrificed mice at stage IV. The time of 
sacrifice was used as a measurement of the total number of survival days. Animal care was 
in accordance with The University of Texas M.D. Anderson Cancer Center guidelines for 
animal experiments.  
 
2.2.2. Virus  
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       ts1, a spontaneous temperature-sensitive mutant of MoMuLV-TB WT, propagates in 
TB cells as a thymus-bone marrow cell line. Virus titers were determined by a modified 
direct focus-forming assay in TB-derived 15F cell line, a murine untransformed, sarcoma 
virus-positive, leukemia negative cell line, as described previously (43).  
 
2.2.3. Cell culture and ts1 infection for cultured astrocytes 
       15F cells and immortalized murine C1 astrocytes were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, 100 units/ml 
penicillin, 100µg/ml streptomycin in a 37oC incubator with 5% CO2 in air. These cells were 
passaged biweekly and used for experiments while in the exponential growth phase. 
Primary astrocytes were isolated from 1 to 2 day-old newborn mouse pups by a method 
described previously (124). In brief, whole brains of each newborn mouse were removed 
and minced separately in ice-cold DMEM/F12 medium. Cell suspension was obtained by 
passing the minced tissue through a 70 mm nylon mesh cell strainer, and plated onto poly-
L-lysine coated 100mm petri dish, and grown in DMEM/F12 medium, supplemented with 
10%FBS, 5 units/ml penicillin, 5 µg/ml streptomycin and 2.5g/ml Fugizone for 4 days in an 
incubator with 5% CO2, atmosphere at 37oC until reaching confluence. At this point, more 
than 99% of the cells in cultures were positive for the astrocyte-specific glial fibrillary acid 
protein (GFAP) marker (125). As noted above, pup genotypes (p53+/+ or p53-/-) were 
identified using standard genotyping PCR on tissue samples and used to label the 
respective primary cultured cells. For infection, 105 cells of C1 or primary cultured 
astrocytes were seeded into 100mm petri dishes. On the second day of culture, all cells are 
treated for overnight with 3µg/ml polybrene and 1% FBS in DMEM for C1 cells or 
DMEM/F12 for primary astrocyte culture (PAC). Cells were then trypsinzed and counted. 
ts1 virus was diluted in the same medium and added to the cells at a multiplicity of infection	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   35	  
(117) of 5 for C1 cells or 20 for PAC for 40 minutes. The cells were washed and incubated 
with normal cell medium containing 10% FBS (94).  
 
2.2.4. ROS measurement 
       Intracellular levels of H2O2 in living cells were measured with 5-(and -6)-chloromethyl-
2’,7’-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA)(Molecular Probes, 
Eugene, OR) as described previously (126). DCFDA is deacetylated by endogenous 
esterases to DCF, which reacts with H2O2 to generate fluorescence. In brief, cells were 
loaded with 20 µM CM-H2DCFDA and incubated at 37oC for 30 minutes. The dye-loaded 
cells are then washed with PBS and the levels of intracellular H2O2 is determined using a 
fluorescent plate reader (Synergy HT, BioTek) at excitation/emission maxima of 488/520nm.  
To determine the levels of O2- production at the mitochondrial membrane in living cells, 
MitoSOX Red (Molecular Probes, Eugene, OR) was used. MitoSOX Red reagent is 
selectively targeted to mitochondria and rapidly oxidized by O2-, but not by other ROS. Cells 
were loaded with 5µM MitoSOX Red and incubated at 37oC for 5 minutes and washed with 
PBS. Levels of the mitochondrial O2- are determined using a fluorescent plate reader 
(Synergy HT, BioTek) at excitation/emission maxima of 530/590nm. 
 
2.2.5. mRNA extraction and real-time PCR 
       C1 astrocytes were infected with ts1 at the multiplicity of infection (117) of 5. mRNA  
was extracted using RNeasy Extraction Kit and Oligotex followed the manufacturer’s 
instruction (Quiagen, Valencia, CA). High Capacity cDNA Archive Kit (Applied Biosystems, 
Foster City, CA) was used to synthesize cDNA by reverse transcription polymerase chain 
reaction (RT PCR) and real-time quantitative polymerase chain reaction (qPCR) 
subsequently performed on the ABI 7900HT Fast Real Time PCR system with primers 
specific to ts1 gPr80env using SYBR Green master mix (BioRad, Inc. Hercules, CA). RNA 
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levels were normalized with the endogenous house-keeping gene, Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). The experimental cycle threshold (127) was 
calibrated against the GAPDH control product and delta delta Ct (ddCt) method was used 
to determine the amount PCR product relative to that of RNA purified from uninfected cells. 
 
2.2.6. Western blot analysis and subcellular protein fractionation 
       C1 or primary astrocytes were washed with PBS and lysed in RIPA buffer as previously 
described (94). Protein concentrations were determined using Bio-Rad Dc protein assay 
reagent (Bio-Rad Laboratories, Hercules, CA). The proteins were separated on SDS-PAGE 
gels, transferred to PVDF membrane, and then immunoblotted with indicated primary 
antibodies. The antibodies used were rabbit anti-phosphorylated p53 (serine15)(Cell 
Signaling, Danvers, MA), mouse anti-phospho ATM (serine 1981), mouse anti-ATM (Novus 
Biological Inc., Littleton, CO), rabbit anti-cleaved caspase 3 (Cell Signaling, Danvers, MA), 
rabbit anti-PUMA (Cell Signaling, Danvers, MA), goat anti-gp70 env, rabbit anti-p30capsid, goat 
anti-gp91phox (Santa Cruz Biotechnology, Santa Cruz, CA), and mouse anti-β actin (Sigma 
Aldrich). After ts1 infection, C1 cells were harvested for fractionations and the cell lysates 
were separated into 5 subcellular fractions (cytoplasmic, membrane, nuclear soluble, 
chromatin-bound and cytoskeletal protein extracts) in accordance with manufacture’s 
protocol (Thermo Scientific, Rockford IL). In brief, cytoplasmic fractions were collected after 
plasma membrane permeabilization. Membrane compartments (plasma membrane and 
organelle membranes) were then dissolved in the membrane fraction. After recovering 
intact nuclei by centrifugation, the agent yielded soluble nuclear extract, and then 
chromatin-bound nuclear proteins were extracted by incubation with nuclease. To verify 
fractionation, 25µl of each extract was analyzed by western blots, using specific antibodies 
against proteins from various cellular compartments including for anti-HSP90 
(cytoplasmic)(Stratagene), calreticulin (membrane) (Cell Signaling, Danvers, MA), histone3 
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(chromatin bound) (Cell Signaling, Danvers, MA), and Bmi-1 (nuclear soluble) (Cell 
Signaling, Danvers, MA) antibodies (data not shown).  
 
2.3.  Results 
 
2.3.1. The early phase of infection in ts1 life cycle 
       As noted in Chapter 1, the life cycle of retroviruses during viral establishment in the 
host cells can be divided into two distinct phases: the pre-integration phase and post-
integration. The pre-integration phase refers to the progression of infection from viral entry 
into the host cells to the integration of the viral DNA into the host cell genome. The post-
integration phase denotes the expression of viral genes and continues through to the 
assembly, release, and maturation of progeny virons (70, 128) (Figure 1.5). To investigate 
ts1 life cycle of viral gene integration into the host cell genome and the process of viral 
replications of viral progeny, we purified mRNA from 2, 4, 8, and 24 hpi, and performed RT 
PCR using viral env gene primers. To quantify RT PCR products, qPCR was performed. As 
shown Figure 2.1, we detected initiation of viral mRNA transcription at 8 hpi. From this 
result, we speculate that the viral proteins detected before 8 hours were most likely protein 
carried by the initial infected viral particles. We then investigated viral protein distribution in 
different subcellular fractions during the pre-integration phase. As shown in Figure 2.2, after 
ts1 infection, viral Env protein detected by anti-gp70 Env antibody was mostly found in the 
membrane fraction at 2 and 4 hpi in very similar levels. Because we did not detect any viral 
gene transcription at 2 and 4 hpi, the envelope protein we observed were therefore from the 
initial viruses fused to the C1 cells. At 4 hpi, more p30capsid was translocated to the nuclear 
membrane as compared to the levels seen at 2 hpi. In studies of HIV, p24capsid penetrates 
the plasma membrane and delivers viral pre-integrated complex to the host nucleus. 
Interestingly, the number of intra-nuclear PICs reached its highest level at 6 hpi (129). As 
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seen in our study, ts1 DNA established in the host genome starts transcription at 8 hpi, 
suggesting that between 4-8 hpi might be relevant to the pre-integration phase in the single 
life cycle of retrovirus-infection in vitro.   
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Figure 2.1. Viral gene transcription in ts1-infected astrocytes.  
C1 astrocytes were infected with the ts1 virus at a MOI of 5. We then harvested cells at 4, 
8, 12, and 24 hpi and purified mRNA. Real time RT-PCR was performed and the relative 
amount of mRNA of viral env is presented after normalization to GAPDH. 
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Figure 2.2.  Subcellular locations of viral proteins in ts1-infected astrocytes. 
At 2 and 4 hpi, C1 cell lysates were isolated into 5 subcellular fractions (cytosolic, 
membrane, soluble nuclear, chromatin-bound, and cytoskeletal fractions). To identify the 
location of viral proteins in the cell, the fractioned samples were probed for anti-
gp70env/gPr80env and anti-p30capsid antibodies. 
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2.3.2. ROS upregulation in the early phase of infection 
       Retrovirus replication requires host cell proliferation because retroviruses depend on 
host resources for replication (43, 130). To access those resources, retroviruses may 
possess mechanisms to activate the host cells. For example, mouse mammalian tumor 
virus (MMTV) activates B cells polyclonally and transiently during the first few hours 
following viral infection, which is independent from T cell mediated activation in the later 
phase (130). HIV virus infectious factor (Vif) mediates G1 to S phase progression for viral 
nucleotides replication (92). We have previously proposed that retroviral infection in the 
quiescent environment of the CNS might act to promote host cell proliferation in order to 
replicate the virus (94). Despite the fact that upregulation of intracellular ROS levels in 
retrovirus-infected cells and tissues has been well-documented (127, 131, 132, 133, 134, 
135, 136, 137), most of these studies assume that ROS upregulation mediated by retrovirus 
infection is associated with cellular apoptosis. Recent studies suggest that intracellular ROS 
levels may have various cellular consequences. For example, high levels of ROS induce 
cell death and growth arrest whereas low levels of ROS mediate cell proliferation (Figure 
1.4). Therefore, it is important to understand the mechanism by which retrovirus-infected 
cells channel ROS into particular signaling pathways spatially or temporally to accomplish 
desired outcomes (62, 95). In particular, the question of how the induction of intracellular 
ROS production contributes to the establishment of a retrovirus in the host cells remains 
underexplored. To investigate the life cycle of ts1 in the context of ROS upregulation, we 
examined intracellular ROS levels after ts1 infection using two different flurorescent probes: 
CM-H2DCFDA to measure intracellular H2O2 levels and MitoSOX Red to selectively detect 
mitochondrial O2-. ts1-infected astrocytes at the indicated times (4, 8, 24, and 48 hpi) were 
incubated with CM-H2DCFDA for 30 minutes, and then DCF fluorescence was measured to 
determine intracellular H2O2 levels. Infected cells were shown to have higher H2O2 levels as 
compared to uninfected cells between 4-8 hours and at 48 hours, but not during 24-48 hpi 
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(Figure 2.3). When we treated cells with anti-oxidant NAC, ts1-mediated ROS upregulation 
disappeared, suggesting that DCF fluorescent signals represent intracellular H2O2 levels. 
As stated above, ROS upregulation has been assumed to come from mitochondria. To 
detect O2- from the mitochondria, we incubated ts1-infected cells with MitoSOX Red. As 
shown in Figure 2.4, O2- released from the mitochondria was detected at 48 hpi, but not at 4 
or 24 hpi. This suggests that H2O2 upregulation in the early phase of infection is not 
originated from the mitochondria during the late phase of infection. Furthermore, we 
observed activated caspase 3 levels during cell death at 48 hpi, suggesting the ROS 
upregulation during the late phase of viral infection may be associated with cell death 
(Figure 2.5). These results provide strong evidence for at least two separate periods of 
H2O2 upregulation. The first with a relatively low H2O2 increase occurs during 4-8 hpi 
whereas the second with a relatively high H2O2 increase appears at 48 hpi.  
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Figure 2.3. Intracellular H2O2 measurement in ts1-infected astrocytes 
C1 cells were infected with ts1. To measure relative intracellular H2O2 levels, cells were 
loaded with CM-H2DCFDA followed by measurement of the relative intensity of fluorescent 
signal. **p < 0.01; ***p < 0.001 when compared with uninfected cells. H2O2 levels at 4, 8, 
and 48 hpi were increased in ts1-infected astrocytes as compared to in uninfected 
astrocytes. Lower intracellular H2O2 levels are present in ts1-infected, NAC-treated cells.  
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Figure 2.4. Mitochondrial O2- measurement in ts1-infected astrocytes. 
C1 cells were infected with ts1 and relative O2- levels were detected by loading with 
MitoSOX-Red and measuring the relative intensity of fluorescent signal. ***p < 0.001 when 
compared with uninfected cells.  
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Figure 2.5. Cellular apoptosis in ts1-infected astrocytes. An apoptotic marker, cleaved 
caspase 3 appeared at 48 hpi whereas translated viral pPr80env did at 24 hpi.  
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2.3.3. p53 does not play an important role in ts1-induced apoptosis. 
       Previous studies showed increased p53 levels in ts1-infected astrocytes and in ts1-
infected mouse brain stem (122). Due to the observation of two distinct phases of ROS 
upregulation in ts1-infected astrocytes, we asked whether ts1-mediated upregulation of 
ROS leads to p53-dependent cell death. To address this question, we injected ts1 virus into 
newborn pups with different p53 genotypic backgrounds. As shown in Figure 2.6, the 
absence of p53 did not prevent ts1-mediated neuropathogenic symptoms in ts1-infected 
mice. Rather p53 knockout mice seemed to show pathological symptoms slightly earlier 
than wild type mice.  We also cultured PACs from p53 +/+ and p53-/- mouse brains and 
compared cell survival after ts1 infection. Our data demonstrated that the absence of p53 
does not prevent ts1-induced cell death as shown in Figure 2.7. Interestingly, p53-/- PACs 
showed higher levels of activated caspase 3 and PUMA (p53 upregulated modulator of 
apoptosis) expression as compared to p53+/+ PACs following ts1 infection (Figure 2.8). 
Interestingly we noticed that PACs were much more resistant to ts1-mediated cell death 
compared to C1 cells. In ts1-infected C1 cells with an MOI of 5, it took 2 days to observe 
significant cell death, whereas in ts1-infected PACs with an MOI of 20 it took 6 days. 
Although previous studies have reported that the progression of cytopathic effects in C1 is 
similar to that in PAC (5, 124), the time period of such progression is much shorter in C1 
compared to PAC. Currently, we do not know why C1 cells are more susceptible to ts1-
induced cell death than PAC. It may be due to the higher proliferative property of C1 cells 
as a result of SV40 large T antigen expression, which is used in cell line immortalization 
(124). Further studies are required to investigate whether highly proliferative cells are more 
susceptible to retrovirus-mediated cytopathogenesis. The fast progression of the virus life 
cycle in cultured C1 has come to be a useful tool in the study of the early phase of the ts1 
life cycle. 
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Figure 2.6. The life span of ts1-infected p53+/+ and p53-/- mice 
2-day-old mice were inoculated intraperitoneally with 50µl of vehicle (mock infection) or a 
ts1 virus suspension containing 1× 107 infectious units (IU)/ml of ts1. Survival curves for 
ts1-infected p53-/- mice (n=6) against survival curves for p53+/+  (n=4) and p53+/- (n=12) 
mice. Log rank test was applied to test if the survival curves are the same. There was no 
significant difference between p53+/+ and p53-/- mice (p=0.496) 
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Figure 2.7. Viable cell count assay of ts1-infected PACs from p53+/+ and p53-/- mouse 
brains. PACs from p53+/+ and p53-/- mouse brains were infected with ts1 at a MOI of 20.  
Viable cells were counted using the trypan blue exclusion method and the viable cell 
number of the ts1-infected group was compared to that of the uninfected in same genotype 
of astrocytes. Error bars represent mean ± SEM from three independent experiments. 
There was no significant difference between p53+/+ and p53-/- PACs. 
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Figure 2.8. ts1-mediated apoptosis in PACs from p53-/- and p53-/- mouse brains. 
After indicated time, protein lysate samples from ts1-infected p53-/- and p53-/- PACs were 
prepared and levels of phoshorylated p53, cleaved caspase 3, and PUMA were compared 
using Western blot analysis. 
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2.3.4. p53 is activated by ROS upregulation in the early phase of infection 
       In the absence of stress, p53 protein levels are kept low by the ubiquitin-mediated 
proteolytic pathway. When cellular stress occurs, p53 is phosphorylated and stabilized as a 
result (138, 139). To investigate if p53 is activated by ROS upregulation, we first examined 
p53 phosphorylation in response to H2O2-treated astrocytes. We treated C1 cells with H2O2, 
and observed p53 phosphorylation and upregulation of intracellular H2O2 (Figure 2.9). As 
shown in Figure 2.7 and Figure 2.8, ts1-mediated cell death occurred in a p53-independent 
manner. We then hypothesized that p53 may be activated as a consequence of early ROS 
upregulation in ts1-infected astrocytes.  As shown in Figure 2.3, ts1-infected cells have 
higher ROS levels than uninfected cells at 4 and 8 hpi. If p53 is activated by ROS 
upregulation, one would expect p53 activation follows ROS upregulation, which occurs at 4-
8 hpi. We observed that p53 phosphorylation was initiated at 8 hpi and reached a peak at 
12 hpi. This phosphorylation appeared to increase total p53 protein level (Figure 2.10) and 
the levels of phosphorylated p53 persisted until cell death occurred. These results suggest 
that ROS upregulation induced by ts1 infection activates p53 during the early phase of virus 
infection in astrocytes.   
                    
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   51	  
 
 
 
Figure 2.9. Upregulation of intracellular ROS increases p53 phosphorylation. 
100µM H2O2 was added to C1 cells for one hour. To determine if phosphorylation of p53 is 
increased by ROS, both p53 phosphorylation and intracellular ROS levels were analyzed. 
To measure intracellular ROS, cells were loaded with CM-H2DCFDA followed by 
measurement of the relative intensity of fluorescent signal. The levels of p53 
phosphorylation were compared using Westernblot analysis. Total protein amounts were 
visualized by p53. Change in 53 levels were not detected within one hour of H2O2 
treatment.  
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Figure 2.10. p53 phosphorylation in ts1-infected astrocytes 
Levels of phosphorylated p53 and total p53 were compared in uninfected and ts1-infected 
samples using Western blot analysis. β-actin was probed as a protein loading control. 
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2.3.5. ATM phosphorylates p53 in response to ROS upregulation 
       ATM, the protein encoded by the ataxia-telangiectasia (A-T) mutated gene, is an 
upstream kinase of p53, which phosphorylates serine 15 of p53 under stressful conditions 
(140). In addition to its role in DNA repair, ATM also plays an important role in regulation of 
cellular redox status (141, 142, 143, 144, 145, 146). It is notable that ROS-induced ATM 
activation is a separate event from the DNA damage response (147). As shown in Figure 
2.11, ATM is activated in H2O2-treated cells. Since ts1 infection upregulated ROS levels 
during the early phase, we aimed to investigate if ATM is activated in ts1-infected 
astrocytes. Cell lysates were prepared and probed with anti-phospho ATM antibody (serine 
1981). As shown in Figure 2.11, ATM activation occurred at 4 hpi, which preceded p53 
phosphorylation at 8 hpi. To examine if p53 phosphorylation relies on ATM activation, we 
treated C1 cells with H2O2 and an ATM inhibitor, Ku55933. We found that this H2O2-induced 
p53 activation was inhibited by Ku55933 treatment. Furthermore, treatment of ts1-infected 
C1 with Ku55933 prevented p53 activation (Figure 2.12). Together these results suggest 
that ATM is a direct upstream kinase for p53 phosphorylation at the site serine 15 in 
response to early ROS upregulation induced by ts1 infection. 
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Figure 2.11. ATM activation in ts1-infected astrocytes and H2O2 treated astrocytes. 
C1 cells were infected with ts1 and harvested cell lysates at 4, 8, and 12 hours post 
infection were analyzed using Western blot analysis to compare the levels of 
phosphorylated ATM. Indicated concentration of H2O2 was added to C1 cells for one hour 
and the cells were subjected to Western blot analysis to compare phosphorylated ATM 
levels. 
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Figure 2.12. Suppression of p53 phosphorylation by inhibiting ATM activation.  
C1 cells treated with 100µM H2O2 were incubated with Ku55933, an ATM inhibitor. Cell 
lysates were then prepared and were compared to examine the levels of phosphorylated 
ATM and p53. Similarly, ts1-infected C1 cells were treated with Ku55933 and examined the 
levels of phosphorylated ATM and p53. 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   56	  
2.3.6. p53 as an intracellular ROS modulator. 
       ts1 infection increases the levels of intracellular ROS in astrocytes, yet, not all ts1-
infected astrocytes die as a result of the ROS upreglation (5). The surviving astrocytes 
during chronic infection with ts1 express higher levels of GSH, suggesting that upregulation 
of antioxidant defenses may be a survival strategy for ts1-infected astrocytes (93). It has 
been demonstrated that expression of p53 appears to increase intracellular antioxidant 
(GSH and NADPH) levels (56, 57, 58). p53 has also been shown to play an important role 
in decreasing ROS levels in various human cancer cell lines through upregulation of anti-
oxidant defense and metabolic enzyme gene transcription (55, 148). By the same token, 
lack of p53 may hamper anti-oxidant defenses in ts1-infected astrocytes. The next step was 
to determine if the absence of p53 dysregulates intracellular ROS levels in astrocytes. To 
address this question, we measured intrinsic intracellular ROS levels in PACs isolated from 
p53+/+ and p53-/- mouse brains. Intracellular ROS levels were higher in p53 -/- PACs 
compared to those in p53 +/+ PACs (Figure 2.13). Furthermore, when both cells were 
treated with the same concentration of H2O2, levels of intracellular ROS were more highly 
elevated in p53-/- cells compared to in p53+/+ cells. This suggests that p53 is involved not 
only in regulating intrinsic ROS levels but also in controlling stress-mediated oxidative 
defenses. Since we observe ROS upregulation in the early phase of infection, viral infection 
appears to enhance intracellular ROS levels independently of the mitochondria. We 
hypothesized that this small amount of ROS upregulation is beneficial for the early viral 
establishment in host cells. As mentioned before, retrovirus may upregulate ROS levels 
leading to activation of host cells to replicate virus progeny. As shown Figure 2.14, 
expression of viral proteins (gPr80env/gp70 and p30capsid) appears earlier in p53+/+ cells 
compared to p53-/- cells when they are infected in same MOI. Interestingly, expressed 
gPr80env was processed into gp70 more efficiently in p53-/- cells than in p53+/+ cells (Figure 
2.14). It is possible that ROS upregulation may facilitate protein folding.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   57	  
 
 
 
 
 
 
 
 
 
Figure 2.13. Intracellular ROS levels in PACs from p53+/+ and p53-/- mouse brains. 
p53+/+ and p53-/-  PACs were untreated or treated with H2O2 for 30 min. The relative ROS 
levels of the PACs were detected by loading with CM-H2DCFDA, followed by measurement 
of the relative intensity of fluorescent signal. ***p < 0.001 when untreated p53+/+ PAC 
compared with untreated p53-/-PAC cells. **p < 0.01; when H2O2-treated p53+/+ PACs 
compared with H2O2 -treated p53-/- PACs.  
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Figure 2.14. Expression of viral proteins in ts1-infected primary astrocytes. 
 PACs from p53+/+ and p53-/- mouse brains were infected with ts1 at the same MOI and 
protein lysates were prepared at 1, 2, 3, 4, 5, 6 dpi. Western blot analysis shows that 
expression of gPr80/70Env and p30capsid appears earlier in p53-/- PAC compared to p53+/+ 
PAC. 
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       We found that gp91phox protein expression level is downregulated in ts1-infected p53+/+ 
PACs and the suppression of gp91phox expression does not occur in p53-/- PACs (Figure 
2.15). This suggests that astrocytes may have a feedback mechanism to suppress levels of 
gp91phox to prevent further oxidative stress and that this appeared to be mediated by p53, 
although we do not know whether the suppression of gp91phox is regulated by p53 directly or 
indirectly.  
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Figure 2.15. Expression of NOX subunits in ts1-infected PACs. 
PACs from p53+/+ and p53-/- mouse brains were infected with ts1 at the same MOI and 
protein lysates were prepared at 1, 2, 3, 4, 5, 6 dpi. Western blot analysis shows the 
expression levels of gp91phox   decreased in ts1-infected p53+/+ PACs while the infection 
process continued. However, ts1-infected p53-/- PACs showed increased gp91phox. 
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2.4. Discussion  
 
       The fact that established retrovirus in the host genome hijacks the host machinery to 
replicate itself is well-known. The retrovirus attempts to establish its gene in the host 
genome and the host may try to protect its genome from viral invasion. However, until 
recently the early battle for cellular control between the retrovirus and the host cell has 
been underexplored. Recent studies suggest that the host cell status is critical for retrovirus 
infection (149, 150). Some retroviruses including MuLV can infect only mitotic cells (149). 
Even HIV cannot infect cells in the permanent resting G0 stage, suggesting that retrovirus 
infection requires partially activated cells (150). We speculate that host cell status could be 
altered by the retrovirus in order to create the optimal environment for cellular invasion. This 
notion is supported by recent studies that show retroviral proteins promoting host cells 
transition to G1/S stages (92) to facilitate integration and replication of the retrovirus. In this 
study, we demonstrated at least two phases of ROS upregulation during ts1 infection. As 
expected, one phase of ROS upregulation occurred during ts1-induced cell death (48 hpi). 
Surprisingly, we also detected another ROS upregulation at relatively low levels between 4-
8 hpi, which is considered as the early phase of infection before expression of viral gene 
expression (Figure 2.16). We speculate that the increased ROS production seen here may 
be involved in retrovirus establishment in host cells. It has also been suggested that low 
levels of ROS act as an intracellular messenger to activate tyrosine kinases or to inactivate 
phosphatases by oxidizing cysteine residues in the active sites (62).  In this study, we 
demonstrated that this transient early ROS upregulation is a separate event from ROS 
upregulation during cell death in ts1-infected astrocytes.  
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Figure 2.16. The life cycle of ts1 and distinct ROS increases in C1 astrocytes. 
After ts1 fuses to host cell membrane (0-2 hpi), the viral PIC enclosed by capsid 
translocates to the host nucleus. While doing so, reverse transcriptase produces viral DNA 
from RNA genome in the host cytoplasm (2-4 hpi). Once viral DNA is integrated into the 
host genome (4-8 hpi), cells start transcription and translation from integrated viral DNA (8-
12 hpi). There are two distinct phases of ROS upregulation. The first ROS increase at low 
levels occurs between 4-8 hpi and high levels of ROS accumulates between 48-72 hpi 
while cell death occurs. p53 phosphorylation is observed at 8 hpi. 
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       Earlier observations, such as upregulation of apoptotic markers and p53 levels in ts1-
infected astrocytes in culture, lead us to hypothesize that p53 may play a role in ts1-
mediated cell death through promotion of pro-apoptotic gene expression (122). However, 
we found that cell death occurs in ts1-infected PACs lacking p53 expression. Wild type 
mice and p53 knockout mice infected with ts1 show no significant difference in 
neuropathological symptoms as illustrated in Figure 2.6. These results are consistent with 
our previous data showing that ts1-infected CNS cells with high levels of p53 expression 
are not associated with morphologic characteristics of dying cells (122). These observations 
suggest that p53 does not play a critical role in ts1-mediated cell death. However, many 
studies have reported that oxidative stress accompanied by upregulation of p53 levels is a 
feature of several viral infections of the CNS (151, 152, 153, 154). From this, we 
hypothesized that the relative low levels of ROS upregulation may initiate p53 activation. In 
this Chapter, we demonstrated that during the early phase of ts1-infection the low level of 
ROS upregulation activated ATM, which in turn, phosphorylated p53. This result is similar to 
a previous study using HIV pseudoparticles in human lymphoblast cells that showed during 
a single cycle of HIV infection to human lymphocytes, reversely transcribed viral DNA was 
first detected at 4 hpi, and then disappeared (155). The exposure of cells to Vesticular 
stomatitis virus (VSV) enveloped-HIV pseudoparticles activates p53 at 4 hours and 
Ku55933 treatment inhibits p53 activation (156). The similarity between previous HIV 
studies and our study implicates that the process of retrovirus infection may initially trigger 
the activation of p53 and ATM during the early phase of infection.  We further argue that 
ATM and p53 may be host defense elements attempting to suppress retrovirus-induced 
ROS induction. Thus, the absence of ATM (141) as well as p53 (Figure 2.13) exposes cells 
constantly to higher levels of ROS, resulting in dysregulation of normal cellular processes. 
Indeed, treatment of mice with anti oxidants extend the life span of cancer-prone p53-/- and 
Atm-/- mice as well as ts1-infected mice (55, 94, 145, 157, 158). A recent study has shown 
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that a mutation of a critical cysteine residue involved in disulfide bond formation specifically 
blocked ATM activation upon ROS treatment without interruption of ATM activation upon 
DNA damage, suggesting a specific role of ATM in the response to ROS (147). 
Furthermore, p53 activation by ATM has been shown to protect DNA from exposure to 
higher ROS levels, rather than repair DNA damage in response to oxidative stress (159).  
        Our study raises two important questions regarding ROS upregulation during ts1 
infection. The first is; what is the source of ROS upregulation during the early phase of ts1 
infection? Although the mechanism by which retrovirus triggers ROS production is at 
present unclear, one of the possible candidates is NOX, which transfers electrons from 
NADPH to O2 producing O2-. In Chapter 3, we show NOX activation during ts1 infection.  
Interestingly, NOX activation also occurs in HIV infection (160, 161, 162) and 
overexpression of SOD, which converts O2-  to H2O2, delays neurodegeneration in the HIV 
mouse model (137). We speculate that ROS upregulation by NOX may be crucial for 
retroviral establishment in host cells. The second question is; what is the role of p53 in the 
response to increased ROS levels in retrovirus-infected cells? We demonstrated that lack of 
p53 increases intracellular ROS levels in astrocytes. We suspect that p53 may induce 
transcription of antioxidant genes, including GSH-generating enzyme GLS2, or NADPH-
inducing enzyme TIGAR. However, we subsequently found  no significant changes in GLS2 
and TIGAR gene transcription in ts1-infected astrocytes and ts1-infected mouse brain (data 
not shown). Although SOD1 is induced by ts1 infection during the early phase of infection, 
we observed that the absence of p53 does not prevent SOD1 induction (data not shown). 
As an alternative, we hypothesized that p53 may suppress prolonged pro-oxidant gene 
expression. In fact, we observed suppression of the protein levels of NOX catalytic subunit 
by p53 in ts1-infected astrocytes (Figure 2.15). We also observed earlier viral protein 
expression in p53-deficient astrocytes compared to wild type cells (Figure 2.14), suggesting 
that sustained ROS upregulation by NOX may potentiate viral gene transactivation 
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employed by ts1. Similarly it has been reported that p53 overexpression inhibits HIV-1 
transcription at viral long terminal repeat (LTR), although p53 is unlikely to bind viral LTR 
directly (163, 164). Early treatment with NAC or upregulation of Nrf2 suppresses Tat-
induced HIV-1 LTR transactivation (165). The delay in virus replication, however, was not 
due to cell death (166).  
       Temporal and spatial ROS regulation is involved in several important aspects of 
retrovirus-induced neuropathogenesis. Previously, ROS upregulation has been assumed to 
be associated with cytopathic effects. We observed that high ROS levels from the 
mitochondria appeared to be connected to ts1-induced cell death whereas low levels of 
ROS upregulation in the cytoplasm is associated with early viral establishment before 
transcription of viral gene integrated in the host genome (Figure 2.2, Figure 2.3). Therefore, 
suppression of the initial phase of ROS upregulation may provide an effective strategy for 
preventing retroviral establishment in the host genome. Furthermore, regulating the levels 
of ROS can be a key determinant of viral latency and replication in astrocytes. Previously 
ts1 has been shown to have enhanced replication in the CNS compared to its parental 
MoMuLV-TB WT (43). The higher viral titer of ts1 compared to MoMuLV-TB WT in the CNS 
seems to correlate with higher ROS production elicited by ts1 infection (5) and the 
treatment of an antioxidant, galavit (GVT) or monosodium luminal (MSL), reduces ts1 virus 
amounts in the CNS (94). In this study, we demonstrated that higher basal level of ROS 
due to the absence of p53 facilitates viral gene expression. Most importantly, ROS 
upregulation in ts1-infected astrocytes likely has profound effects on the microenvironment 
of neurons. Astrocytic support is crucial to neuronal protection from ROS damage in various 
neurodegenerative disease models (54, 167, 168, 169). ts1 infection causes thiol depletion 
in astrocytes (5). In a previous study in our laboratory, minocycline treatment prevented 
death of cultured astrocytes infected by ts1 through oxidative stress attenuation without 
affecting virus titers. Furthermore, minocycline prevented death of primary neurons when 
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cocultured with ts1-infected astrocytes through ROS suppression and Nrf2 promotion (126).  
In summary, we propose that a better understanding of the retrovirus-induced upregulation 
of ROS in the context of virus-host cell interaction may lead to improved treatment 
strategies for retrovirus-induced neurodegeneration. Effective targets for pharmacological 
and transgenic antioxidant therapies will require further investigation. 
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Chapter 3. ts1 infection activates NOX in the early stage of virus life cycle  
 
3.1. Introduction 
 
       In Chapter 2, we divided the ts1 life cycle in astrocytes into the pre-integration and 
post-integration phases based on viral gene integration into the host genome. The 
integrated viral gene transcription begins at approximately 8 hpi. In the post-integration 
phase, the newly synthesized translated ts1 Env protein cannot be properly folded. As a 
result of misfolding, it is accumulated in the ER, leading to ER stress and eventually to cell 
death. We observed at least two different phases of ROS upregulations in ts1-infected 
astrocyte cultures. The first one occurs during early retroviral establishment (pre-integration 
phase). The early ROS upregulation is relatively low compared to the ROS levels in the late 
phase and is unlikely to be released from the mitochondria or ER (Figure 1.4). On the 
contrary, the second ROS upregulation appears to be due to O2- released from the 
mitochondria while the cell death pathway is activated. We hypothesized that the first stage 
of ROS upregulation is caused by NOX and that the early increase in ROS may be involved 
in the early establishment of retrovirus in the host cells.     
 
3.1.1. NOX in ts1-induced neurodegeneration 
       A great deal of research has focused on NOX because it was the first inducible system 
identified with intended ROS generation. Conversely, O2- production in the mitochondria is 
an unintended output as a byproduct of energy metabolism. Use of cell-free systems led to 
the discovery of the different roles for NOX subunits, p47phox, p67phox, Rac and p40phox. The 
current working model of the NOX complex is as follows: phosphorylation of p47phox leads to 
a conformational change allowing its interaction with p22phox, which in turn allows p47phox to 
bring p67phox into contact with catalytic subunit gp91phox.  When this occurs, the GTP bound 
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Rac interacts with the gp91phox, and subsequently interacts with p67phox. The complex is 
capable of generating O2- by transferring electrons from NADPH to O2 (Figure 3.1) (170).  
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Figure 3.1. The current model of NOX complex activation in phagocytes. Upon the 
activation signal, the cytoplasmic subunits including p40phox, p47phox, p67phox are 
translocated to transmembrane subunits (gp91phox and p22phox). A small GTPase protein 
Rac then interacts with NOX complex. Subsequently, NOX complex transfers an electron 
from NADPH to O2 and generates a respiratory O2- burst in the extracellular environment.
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       ts1 cannot infect non-dividing neurons, however neuronal death is apparent in the ts1-
infected CNS. There is growing evidence that ROS cause ND via non-cell autonomous 
mechanism (171, 172). We believe that ts1 infection causes ROS upregulation in 
astrocytes. Due to that, infected astrocytes are unable to provide adequate antioxidant 
defenses to neurons. As a consequence, neurons may die. Previously it has been shown 
that antioxidant treatment prolonged ts1-infected mouse life span (94). Furthermore, 
oxidative stress caused by ts1 infection has been established through demonstration of 
cysteine depletion in brain stem tissue slice culture (Lungu Gina, unpublished data) and 
decrease of GSH levels in ts1-infected astrocyte culture (5). However, until now, the source 
of ROS production in ts1-infected astrocytes was unclear. In this study we demonstrate that 
activation of NOX is one of the sources of ROS production in ts1-infected astrocytes and 
that NOX activation is unlikely to play a direct role in ts1-mediated astrocytic cell death. 
Furthermore, NOX appears to play an important role in viral gene integration into the host 
genome. Consistent with the results from in vitro experiments, we also observed decreased 
viral replication and delayed onset of neuropathological symptoms in ts1-infected mice 
when the mice were treated with NOX inhibitor. 
 
3.2. Materials and Methods 
 
3.2.1. NOX activity assay  
       To determine NADPH levels in the cytoplasm, NADPH assay kit (BioVision, CA) was 
used following instruction of manufacturer. Briefly, cells were trypsinized and washed with 
PBS following apocynin treatment. NADPH is extracted from the cell pellets (5X105 cells) 
and incubated with an enzyme mixture and colormetric developer for 1 hour at 37oC. After 
reaction, the reaction mixtures assayed at Abs450nm using a plate reader. NADPH (0. 20, 
40, 60, 80, 100 pmol) was also incubated with an enzyme mixture and the developer to plot 
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the NADPH standard curve (data not shown).  To measure the relative amount of O2- 
production, the same number of cells (1 X104 cells/per well) were placed in 24-well plate 
and infected with ts1. Following infection, cells were washed with PBS and incubated with 
50mM oxidized cytochrome c (Sigma Aldrich) in PBS (pH 7.4) for 1 hour at 37oC. The 
absorbance at OD550 was measured before and after the reaction, and the change of 
Abs550 was calculated. As a negative control, 5 units of purified SOD (Sigma Aldrich) were 
added with oxidized cytochrome c. To detect O2- levels in the CNS, DHE was applied to 
uninfected mice or 30 days post ts1 infected mice as described (53). Briefly, two serial 
intraperitoneal injections of freshly prepared dihydroethidium (DHE) (Molecular Probes, 
Eugene, OR) (27 mg/kg) were given at 30 minute-intervals. After 18 hours, mice were 
perfused intracardially with cold saline followed by 4% paraformaldehyde in PBS for 
immunohistochemistry experiments. The whole brain is incubated in 30% sucrose solution 
overnight and frozen in optimal cutting temperature (OCT) embedding medium (Sakura 
Finetek, Inc., Torrance, CA) for frozen-section for immunohistochemistry  
 
3.2.2. Apocynin treatment to ts1-infected mice. 
       To test the animal affect of apocynin treatment on ts1-mediated neuropathogesis, 
mouse pups at 2 days post natal were infected with ts1 and divided into two groups, one 
group receiving normal saline and the other receiving freshly prepared 100mg/kg of 
apocynin (Sigma Aldrich) (amount/body weight) delivered intraperitoneally for five 
continuous days per week, followed by two resting days. Mice from all groups were 
checked daily for clinical signs of disease and sacrificed when moribund and paralyzed. All 
animal procedures were performed according to protocols approved by The University of 
Texas M. D. Anderson Cancer Center Institutional Animal Care and Use Committee. 
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3.2.3. Tissue virus titer assay 
       The virus titer assay was performed as described in (94). Briefly, brainstems were 
removed at 30 days post infection (dpi), snap-frozen in liquid nitrogen and kept frozen until 
they were used. Frozen brainstem tissues were weighed and then homogenized (40 
strokes) (Kontes Glass Co., Vineland, NJ) in 2 ml ice-cold basal DMEM. Cell debris was 
removed by filtration through a 0.45-µm syringe filter (Pall Corporation, Ann Arbor, MI). The 
titers (IU/ml) of ts1 in these lysates were determined using a modified 15F assay as 
described before. The titer of virus was taken as the average titer from three to six mice. 
 
3.2.4. Immunohistochemistry and immunocytochemistry 
       For immunohistochemistry, frozen mouse brain tissues were sliced into 6 µm sagittal 
sections encompassing the brain stem region. Brains tissue slices were washed in PBS and 
incubated in 5% normal donkey serum in PBS/0.1% Triton X-100 for 1 hour at room 
temperature. Primary antibodies (GFAP: 1: 200, NeuN: 1:1000, and p30capsid: 1:500,) were 
diluted in 5% normal donkey serum in PBS and applied to the slices for one hour at room 
temperature, after which the slices are washed in PBS and incubated in a 1:500 dilution of 
TexasRed conjugated donkey anti-goat IgG or Fluorescein isothiocyanate (FITC)-
conjugated donkey anti-mouse IgG antibodies for one hour at room temperature and 
mounted sequentially in glass slides using prolong antifade reagent containing 4',6-
diamidino-2-phenylindole (DAPI) (Molecular Probes, Eugene, OR). 
       Uninfected control or ts1-infected C1 cells were placed on poly-L-lysine coated 
coverslips and fixed in 4% paraformaldehyde for 20 minutes, then washed with PBS. The 
fixed cells were incubated in PBS containing 0.05% Tween 20 and 5% donkey serum for 30 
minutes and washed with PBS. The coverslips were then incubated with goat anti-
gPr80env/gp70env antibody followed by anti-goat IgG secondary antibody conjugated with 
Texas Red (Jackson Immunoresearch, West Grove, PA). As an immunostaining control, 
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mouse anti-β tubulin antibody (Sigma Aldrich) and anti-mouse IgG secondary antibody 
conjugated with FITC (Jackson Immunoresearch, West Grove, PA) were used. The stained 
coverslips were mounted on slide with Prolong anti-fade mounting reagent (Molecular 
Probes, Eugene, OR) containing DAPI.   
 
3.2.5. Genomic DNA preparation and quantitative PCR 
       C1 astrocytes were infected with ts1 at a MOI of 5. The control group was not treated 
with any drug, and the other two groups are treated either with 10mM NAC or 1mM 
apocynin. mRNA was extracted using RNeasy extraction kit and Oligotex, following the 
manufacturer’s instruction (Quiagen, Valencia, CA). Genomic DNA was purified using the 
genomic DNA extraction kit, following the manufacturer’s instruction (Promega, Madison, 
WI). High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA) was used to 
synthesize cDNA and qPCR was subsequently performed on the ABI 7900HT Fast Real 
Time PCR system with primers specific to ts1 gPr80env using SYBR Green master mix 
(BioRad, Inc. Hercules, CA) (173). RNA levels were normalized to the endogenous house-
keeping gene GAPDH. The experimental Ct was calibrated against the GAPDH control 
product and ddCt method was used to determine the amount PCR product relative to that of 
RNA or genomic DNA purified from uninfected cells 
 
3.3. Results  
 
3.3.1. Cellular distribution of NOX subunits in astrocytes  
       The current model of NOX activation is based on phagocytic cells. It is known that 
catalytic subunit gp91phox is localized at the plasma membrane. Upon translocation of 
cytoplasmic subunit p47phox to the membrane, its partner p67phox is also translocated to the 
membrane and turns on the catalytic activity of p91phox. We examined p67phox and p47phox 
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localization in our system to verify NOX activation after ts1 infection. C1 cells were lysed 
after ts1 infection, and fractionated into four different subcellular fractions; cytoplasmic, 
membrane, soluble nuclear and chromatin bound insoluble nuclear fractions. As expected, 
gp91 phox was nonetheless localized at the membrane fraction in any case and p47phox 
existed predominantly in the cytoplasm of uninfected cells (Figure 3.2). To our surprise, we 
observed that p67phox was primarily localized at the membrane instead of the cytoplasm 
regardless of the status of ts1 infection in the astrocytes. It is noteworthy that the 
membrane fraction includes not only integral proteins at the plasma membrane but also 
proteins from membrane bound organelles, such as the ER and mitochondria. Following ts1 
infection, p47 phox is translocated from the cytoplasm to the membrane as shown in Figure 
3.2. We also observed p47phox protein band shift in western blotting analysis, suggesting 
posttranslational modification. This lower band of p47phox only appeared when cells were 
infected with ts1. At present we do not know whether the localization of p67phox at the 
membrane is a characteristic specific to astrocytes. 
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Figure 3.2. Cellular distribution of NOX subunits in C1 astrocytes. 
C1 cells were lysed after ts1 infection and fractionated into four different subcellular 
fractions, cytoplasm, membrane, soluble nuclear and chromatin bound insoluble nuclear 
fractions. gp91 phox and p22 phox are nevertheless localized at the membrane fraction. 
p47phox exists predominantly in the cytoplasm of uninfected cells and translocates to the 
membrane after ts1 infection. p67phox is primarily localized at the membrane instead of the 
cytoplasm regardless of the status of ts1 infection status in the astrocytes. To verify the 
fractionation, anti-HSP90 (cytoplasmic), calreticulin (membrane) and H3 (chromatin bound) 
antibodies were used followed manufacture’s information. 
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3.3.2. NOX is activated in ts1-infected astrocytes 
       As mentioned above, p67phox in astrocytes is already located at the membrane 
regardless of ts1 infection. Therefore, we could not verify NOX activation by the activator of 
catalytic subunit gp91phox, p67phox translocation in ts1-infected astrocytes as seen during 
NOX activation from other systems (174). Therefore, we first needed to develop NOX 
enzyme activity assays. Although we observed p47 phox translocation, it was still not clear 
whether post-translational modification and translocation of p47 phox are directly related to 
NOX activation. The activated NOX complex consumes NADPH in the cytoplasm, and 
transfers electrons to oxygen, thereby generating O2-. This sequence of events allows us to 
detect the change of NOX activity by measuring the substrate (NADPH) and product (O2-) 
of NOX to determine whether ts1 infection of astrocytes activates NOX (Figure 3.3). We 
compared NADPH levels in ts1-infected astrocytes to levels in uninfected astrocytes. As 
shown in Figure 3.3, the NADPH levels were decreased in ts1-infected astrocytes. The 
results showed that ts1-infected cells treated with NOX inhibitor, apocynin, had unchanged 
NADPH levels, suggesting that decreased NADPH in ts1-infected astrocytes is due to NOX 
activation. We then investigated if ts1-infected astrocytes change O2- production in living 
cells. The heme group in cytochrome c preferentially accepts singlet electron from O2-.  
Reduced cytochrome c was measured by the increase in absorbance at 550nm. Therefore, 
this reaction provides a useful tool to distinguish O2- from other ROS. We added oxidized 
cytochrome c to uninfected and ts1-infected astrocytes and then measured the change of 
Abs550 after incubation with oxidized cytochrome c (Figure 3.3). We observed increased 
O2- in ts1-infected astrocytes compared with those in uninfected astrocytes. We added 
purified SOD as a control sample. We hypothesized that if ts1 infection causes O2- 
production, the extracellular O2- can be immediately converted to H2O2 by SOD. We 
confirmed that there would not be singlet electron transfer to cytochrome c in the ts1-
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infected astrocytes with SOD. Together these results suggest that NOX is activated by ts1 
infection and releases O2- to the extracellular microenvironment (Figure 3.3).  
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Figure 3.3. NOX activation in ts1-infected astrocytes. 
The schemetic diagram of experimental design (top). The heme group in cytochrome c 
preferentially accepts singlet electron from O2- and reduced cytochrome c was measured by 
the change in absorbance at 550nm. NADPH levels decreased in ts1-infected astrocytes. 
Apocynin treatment reverses NADPH levels.  O2- production is upregulated in ts1-infected 
astrocytes compared with that in uninfected astrocytes. O2- production disappears with the 
addition of SOD in the medium.
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3.3.3. NOX activation occurs in early phase of ts1 infection 
       In Chapter 2, we observed two distinct phases of ROS upregulation in ts1-infected 
astrocytes. The first phase of ROS upregulation occurred at 4-8 hpi coinciding with early 
viral establishment followed by a second phase during cell death (48 hpi). Therefore, we 
further investigated NOX activities focusing on the phases of infection. As shown in Figure 
3.4, the substrate of NOX (NADPH) was decreased at 4-24 hpi. However, O2- production 
was increased only at 24 hpi, but not at 4 hpi in the extracellular environment (Figure 3.5).  
Considering that H2O2 levels measured by DCF fluorescence were upregulated only at 4-8 
hpi but not at 24 hpi (Figure 2.3), we suspected that intracellular SOD might attempt to 
reduce the upregulated O2- immediately by converting O2- to H2O2 after ts1 infection. Indeed, 
we observed higher levels of SOD levels in the cytoplasm at 2 and 4 hpi (Figure 3.6). To 
investigate if there was any change in local distribution of SOD at 4 hours in ts1-infected 
cells, we immunostained uninfected and ts1-infected astrocytes using anti-SOD antibody. 
Upregulated SOD is accumulated in the perinuclear area at 4 hpi in ts1-infected astrocytes 
whereas SOD in uninfected cells distributes evenly throughout the cytoplasm (Figure 3.7). 
Corresponding to SOD redeployment, we do not observe H2O2 levels increase at 24 hpi 
following ts1 infection (data not shown). It appears that early activation of NOX coincides 
with the redistribution of SOD in the early phase of infection. Once the virus establishes its 
presence in the host genome, SOD rearrangement did not occur any more although 
extracellular O2- production increased at 24 hours after ts1 infection. We did not observe 
any changes in the levels of NADPH at 48 hpi following ts1 infection, suggesting that NOX 
activation is not involved in the apoptotic process after ts1 infection. 
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Figure 3.4.  Measurement of intracellular NADPH levels during ts1 life cycle 
Cellular NADPH levels were measured from the cells collected as time indicated after ts1 
infection as described in Material and Methods. NADPH levels are decreased at 4-24 hpi, 
however there was no difference in 48 hpi regardless of ts1 infection status. Treatment of 
apocynin reverses NADPH consumption in ts1-infected cells. 
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Figure 3.5. Measurement of extracellular O2- production during ts1 life cycle. 
Extracellular O2- levels were measured after ts1 infection as described in Material and 
Methods. O2- production is increased only at 24 hpi, however no difference at 4 hpi. 
Addition of SOD in the culture reverses O2- production. 
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Figure 3.6. SOD upregulation in the early phase of ts1-infection. 
The levels of intracellular SOD are increased in the cytoplasm at 2 and 4 hpi but there are 
no changes in levels of p47phox and p67phox. C  and M represent cytoplasmic and membrane 
fractions. PKCα (cytoplasmic protein) was used for protein loading control.  
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Figure 3.7. Redistribution of SOD during the early phase of ts1 infection. 
 SOD was immunostained using anti-SOD antibody in uninfected and ts1-infected 
astrocytes. Upregulated SOD is accumulated in the perinuclear area at 4 hpi in ts1-infected 
astrocytes (blue, DAPI; red, gp70env; green, SOD1). 
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3.3.4. O2- upregulation by NOX activation may enhance viral gene integration into 
host genome. 
       It is possible that NOX activation in the early phase of ts1 infection may be a “priming” 
process to turn on intracellular signal transduction pathways that are necessary for viral 
establishment in the host genome. In other words, ROS upregulation by NOX activation at 
the membrane after initial contact with viral envelope protein may not have a completely 
detrimental effect on the cells in causing cell death because NOX activation is not detected 
in the last phase of infection.  We hypothesized that NOX activation at the early phase of 
virus infection may facilitate the integration of viral DNA into the host genome. In Chapter 2, 
we observed that viral gene transcription from the integrated viral genome started 
approximately at 8 hpi (Figure 2.1). Along with intracellular ROS, particularly H2O2, at 4-8 
hpi following ts1 infection, SOD redistribution at the perinuclear area suggests that H2O2 
converted from O2- by SOD may allow viral DNA to access the host nucleus. To investigate 
whether ROS upregulation by NOX activation is involved in early viral establishment in the 
host genome, we treated ts1-infected C1 cells with apocynin or NAC. We then investigated 
viral env DNA from purified host genomic DNA using qPCR analysis. As shown in Figure 
3.8, genomic DNA purified from apocynin or NAC-treated, ts1-infected cells contains 
significantly lower viral env gene compared to that from untreated ts1-infected cells. We 
also observed that apocynin-treated cells have lower env transcription, which further 
supports the concept of decreased viral gene integration into the host by inhibition of NOX. 
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Figure 3.8. Inhibition of NOX decreased viral establishment into the host genome  
 ts1-infected C1 cells were treated with apocynin or NAC. Viral env DNA integrated into the 
host genomic DNA was quantified using qPCR. Genomic DNA purified from apocynin or 
NAC-treated cells had significantly lower viral env gene compared to that from untreated 
cells. Apocynin-treated cells shows lower env transcription, supporting decreased viral gene 
integration into the host by inhibition of NOX.
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       To validate that the in vitro result shown here correlates to the in vivo results from the 
brain, we hypothesized that inhibition of NOX may decrease viral titer in the ts1-infected 
mouse brain. We infected two groups of mice with ts1, one with apocynin treatment and the 
other without treatment. In 30 days of ts1 infection, we dissected brain stems from 
untreated and apocynin treated, infected mice and performed viral titer assays. As expected, 
lower viral titer was observed in apocynin-treated mouse compared to untreated ts1-
infected mouse as shown in Figure 3.9. These results suggest NOX activation is involved in 
early viral establishment in ts1-infected cells.    
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Figure 3.9. ts1 viral titer assay in the apocynin-treated mouse CNS  
Two groups of mice were inoculated with ts1, one with apocynin treatment and the other 
without treatment. After 30 days of infection, brain stems of infected mice were dissected 
and viral titer assays were performed using the tissues. Lower viral titer was observed in 
apocynin-treated mice compared to untreated ts1-infected mice. 
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3.3.5. O2- production increased in the ts1-infected mouse brain stems  
       To replicate retrovirus, cells must be highly proliferative. However, the quiescent 
environment of the CNS does not favor high viral replication. This may explain why the 
cytopathic effect of ts1 infection seems much more severe in vitro as opposed to in vivo. As 
described above, we demonstrated that NOX is activated in ts1-infected astrocytes in vitro 
(Figure 3.3). However, we still do not know if NOX is activated in the ts1-infected mouse 
brain. To determine if O2- is increased in the ts1-infected brain, we injected DHE 
intraperitoneally into both uninfected and infected mice. DHE is a cell-permeable probe, 
which undergoes oxidation in the presence of O2- leading to the formation of fluorescent 
ethidium. We observed stronger DHE fluorescence in ts1-infected brain stems near 
spongiform lesions compared to normal uninfected brain stems, suggesting that O2- 
production is increased in the ts1-infected brain stem (Figure 3.10). Although higher DHE 
fluorescence was detected overall in ts1-infected brain stem tissues, it appeared in several 
distinct spots. These areas did not overlap with anti-GFAP immunostainings (Figure 3.10). 
To verify if DHE fluorescent cells are astrocytes (GFAP positive cells), we immunostained 
GFAP and labeled nuclei with DAPI.  As shown in Figure 3.11, we observed that O2- 
increased in GFAP-positive cells as well as some GFAP-negative cells. Interestingly, the 
subcellular O2- detected by DHE seemed to be more concentrated in cell body near the 
perinuclear area where cytoskeletal GFAP was not stained (Figure 3.11). GFAP are mostly 
localized at the cellular periphery. GFAP-positive cells were closely localized near neurons 
(NeuN-positive cells) in the CNS as shown in Figure 3.12. We attempted to detect the 
localization of viral proteins in the ts1-infected mouse CNS by performing 
immunofluorescence using anti-p30capsid antibody. GFAP-positive cells were infected by ts1. 
Viral capids were localized in both peripheral regions and the cell body area in astrocytes 
(GFAP positive cells) in the ts1-infected mouse CNS (Figure 3.13). We also noticed that 
some GFAP-negative cells were infected by ts1. We do not know what type of cells they are 
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and how they contribute to the neuronal microenvironemnt at present. 
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Figure 3.10. O2- upregulation and reactive gliosis in the ts1-infected CNS  
Freshly prepared DHE solution was injected intravenously into both uninfected and infected 
mice (30 dpi). Brain stem tissue sections were fixed in paraformaldehyde and used for 
immunostaining using anti-GFAP (14). Stronger DHE fluorescence (red) in ts1-infected 
brain stems is shown near spongiform lesions compared to normal uninfected brain stems.  
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Figure 3.11. The subcellular O2-  upregulation in the perinuclear area of the ts1-
infected CNS cells. Brain stem tissue sections from DHE injected, ts1-infected mice were 
prepared as described in Materials and Methods, followed with immunostaining with anti-
GFAP antibody. White arrows represent the GFAP positive cells with high DHE, and gray 
arrows represent the GFAP negative cells with high DHE. The subcellular O2- detected by 
DHE seemed to be more concentrated in cell bodies near the perinuclear area where 
cytoskeletal GFAP were not stained. 
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Figure 3.12. Intimate location of astrocytes and neurons in the CNS. 
GFAP (red) positive astrocytes are located closely to NeuN (14) positive neurons. 
Astrocytic peripheral feet stained by GFAP surrounded neurons. Blue, DAPI. The white 
arrows indicate astrocytes (GFAP positive, NeuN negative). The area stained with GFAP is 
not overlapped with DAPI stained area, indicating that GFAP is not staining perinuclear 
area. 
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Figure 3.13. Astrocytes are infected by ts1 in the CNS 
 Viral p30capsid (14) were observed at both peripheral and perinuclear regions in GFAP-
positive astrocytes. White arrows represent the GFAP (red) -positive cells with ts1 infection. 
Gray arrows represent the GFAP-negative cells with ts1 infection, indicating there may be 
either GFAP-negative astrocytes or some cell types other than astrocytes.  
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       To verify that the O2- upregulation was caused by NOX activation in the ts1-infected 
brain stem, we treated the ts1-infected mice with apocynin. Our results showed that 
apocynin treatment reduced overall DHE fluorescence levels in the ts1-infected mouse 
brain stem including astrocytes (Figure 3.14). NOX was expressed in neurons and 
detrimental effects of NOX activation in neurons have been reported (53). To identify 
whether neurons have higher O2- levels after ts1 infection, we immunostained brain stems 
of DHE-injected animals with anti-NeuN (neuronal marker) antibodies. We observed lower 
DHE fluorescence in NeuN positive cells in apocynin treated, ts1-infected mouse brain 
stems as compared to untreated ts1-infected mouse brain stems (Figure 3.15). These 
results suggest that NOX activation following ts1 infection causes oxidative stress in 
neurons. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   95	  
 
 
 
Figure 3.14. Inhibition of NOX decreased O2- levels in the ts1-infected CNS. 
 Freshly prepared DHE solution was injected intraperitoneally into both uninfected and 
infected mice. Brain stem tissue sections from the mice were prepared as described in 
Material and Methods followed by immunostaining using anti-GFAP (14) antibody. DHE 
(red) represent O2- and apocynin treated CNS has overall lower DHE fluorescence.
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Figure 3.15. Inhibition of NOX decreased neuronal O2- levels in neurons of ts1-
infected CNS.  DHE injected animals were sacrificed and immunostained for NeuN (14). 
DHE (red) represent O2- and apocynin treatment decreased DHE fluorescence levels in 
neurons of ts1-infected CNS.
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3.3.6. Inhibition of NOX prevents ts1-mediated cell death and prolongs the life span 
of ts1-infected mice 
       ts1 infection in astrocytes is a known cause of cell death. To investigate if the inhibition 
of NOX activation could prevent cell death, we treated ts1-infected astrocytes with apocynin. 
Viable cell counts of ts1-infected astrocytes with or without apocynin treatment confirmed 
that apocynin prevents ts1-mediated cell death significantly (Figure 3.16).  Previous work 
from our lab has shown that ts1 infection increases caspase-3 activation, and decreases 
Bcl2 levels in astrocytes (48). We questioned whether the inhibition of NOX affects cell 
death after ts1 infection. To determine if NOX plays a crucial role in inducing apoptosis, we 
utilized pro-apoptotic and anti-apoptotic markers in ts1 infected astrocytes cultures. Our 
results showed that NOX inhibition increased Bcl-2 levels, and decreased activated 
caspase 3 levels. These results suggest that inhibition of NOX decreases ts1-mediated 
astrocytic death. This may be due to suppression of viral replication as shown in Figure 3.9. 
Furthermore, inhibition of NOX with apocynin treatment extends life span of ts1-infected 
mice, as shown in Figure 3.18. ts1 has a more potent cytopathic effect than MoMuLV-TB 
WT. Although MoMuLV-TB WT has a cytopathic effect on astrocytes, lesions in the WT-
infected brain are much less severe when compared to those in the ts1-infected brain. WT 
virus does not cause neuropathological symptoms in mouse, such as hind limb paralysis 
(34). The neurovirulent effect of ts1 is due to the accumulation of misfolded viral env protein 
in the ER resulting in UPR and resulting in cell death. To determine if NOX inhibition affects 
ts1-induced UPR, we treated ts1-infected astrocytes with apocynin and examined BiP as an 
indicator of the ER stress.  Apocynin treatment did not change BiP upregulation despite low 
viral replication as shown in Figure 3.17 and Figure 3.8, indicating that O2- generation by 
NOX activation and UPR are likely to be triggered by separate signaling pathways. It is 
noteworthy that gPr80env processing was improved in p53-/- PACs (Figure 2.15). We 
suspect that gp91phox upregulation due to the absence of p53 may facilitate protein folding. 
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By suppressing NOX, gPr80env folding may be less efficient despite less viral replication. 
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Figure 3.16. Inhibition of NOX activation prevented ts1-mediated astrocytic cell death.  
Viable cell number was counted from ts1-infected astrocyte culture with or without apocynin 
treatment and then compared with the cell number of uninfected controls. The value of 
percentile of infected cells are presented. p < 0.05 when apocynin treated cells compared 
with untreated p53-/-PAC cells. 
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Figure 3.17. Inhibition of NOX suppressed ts1-mediated apoptosis, but not the ER 
stress.  The cell lysates showed increased Bcl-2 and decreased activated caspase 3 levels 
in ts1-infected astrocytes by apocynin treatment. However apocynin treatment did not 
change the expression of gPr80env and BiP, suggesting no difference in ER stress caused 
by ts1 infection. 
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Figure 3.18. Inhibition of NOX activation extended the life span of ts1-infected mice.  
Twenty two mice were infected with ts1. 2 days after birth then divided into two groups. 3 
days after ts1 inoculation, nine mice received intraperitoneal injections of 100mg/kg of 
apocynin, and the other thirteen mice received the same volume of normal saline. 
Treatment was continued for 5 days/week (p value<0.01).   
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 3.4. Discussion 
 
       As mentioned before, ts1 cannot infect neurons. However, neurons die as a result of 
ts1-infection in the mouse brain. The infection of astrocytes causes neuronal cell death as 
evidenced by neuron-astrocyte coculture experiments (126). In Chapter 2, we observed 
ROS upregulation at 4-8 hpi in astrocyte culture. This occurs in the early phase of retrovirus 
infection and we hypothesized that this ROS upregulation was associated with retroviral 
establishment in the host genome. The ROS are unlikely to come from the mitochondria or 
ER. Instead, we suspect that early ROS upregulation is accomplished by NOX activation. In 
this Chapter, we investigated activation of NOX in ts1-infected astrocytes and attempted to 
correlate the phenomena to ND in ts1-infected mouse.  
       Until recently, little was known about the role of NOX in the CNS and NOX was 
primarily studied in immune cells. However, recent studies demonstrate that NOX 
components are expressed in non-immune cells including astrocytes and neurons (53, 54). 
Studies from Chapter 2 and 3 show that not all ROS are equivalent. The temporal (4, 24, 
and 48 hpi) and spatial (mitochondria, cytoplasm, extracellular microenvironment) ROS 
appear to be controlled by different cellular sources. We demonstrated NOX activation in 
ts1-infected astrocytes by measuring the levels of NADPH (substrate) and O2- (product). 
The data clearly indicate that NOX activation occurs between 4 to 24 hpi in ts1-infected 
astrocytes, which is independent of the ts1-mediated cell death process. Furthermore, 
distribution of cellular ROS scavenging enzymes also impacts local ROS signaling initiated 
by O2- production (47). We found that intracellular H2O2 upregulation at 4 hpi is likely due to 
upregulation of both NOX and SOD1 whereas O2- upregulation at the plasma membrane at 
24 hpi is due solely to NOX activation.  
       The entry of viral envelope protein may trigger host cell changes. Most retroviruses, 
including HIV, penetrate host cells through fusion with the host plasma membrane by 
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binding to specific receptor or through endocytosis. It has been shown that CD4-
independent HIV-1 entry occurs through endocytosis (175, 176). The route of entrance to 
the host cytoplasm appears to be cell type-dependent. For example, ecotropic MLV invades 
NIH 3T3 cells by endocytosis, whereas it enters rat XC cells by fusion at plasma membrane 
(177). In particular, endocytosis enables formation of microdomains that contain different 
microenvironments different from the cytoplasm. Short-lived O2-, which can be converted to 
long-lived and diffusible ROS derivatives, increases high ROS concentration in the 
microdomains on a low global ROS background. High levels of ROS in a specific location 
may activate ROS signaling pathways while global intracellular ROS concentrations remain 
low. It is noteworthy that at 4 hpi, intracellular NADPH levels decreased without detection of 
extracellular O2- upregulation. Recent studies also show CD4-independent HIV infection 
and MLV infection involving inhibition of cathepsin B in endosomes, increasing host cell 
susceptibility to viral infection (178, 179). Surprisingly, NOX activation specifically 
suppresses cysteine proteases (cathepsin B/L) via reversible oxidation of cysteine 
cathepsins within the phagosome (180).  We presume that there may be two phases of 
NOX activation followed by ts1 infection. During the pre-integration phase, viral particles 
penetrate the host membrane via endocytosis. In the endosomes, the first phase of NOX 
activation by ts1 may inhibit cysteine proteases and this may protect the viral capsid from 
lysis. Interestingly, we observed that SOD localization in the perinuclear area within 4 hpi. 
We suspect that localization of SOD in the virus containing endosomes may be an attempt 
by the host cell to prevent the preintegrated viral complex access to nuclear membrane. As 
shown in Figure 3.8, inhibition of NOX decreased viral establishment in the host genome. 
SOD1 overexpression has been shown to prevent neuronal death in HIV env expressing 
mouse brain. Our study demonstrated that upregulated O2- was more highly detected in the 
cell body rather than in the periphery of cells in the ts1-infected brain stem.  
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       At 24 hpi, we observed p47phox translocation from the cytoplasm to the plasma 
membrane and O2- production in the extracellular environment without SOD redistribution 
toward the plasma membrane, which is the second phase of NOX activation. We 
hypothesized that NOX activation at the plasma membrane may be used by the virus as a 
mechanism to stimulate cell proliferation. Extracellular O2- may eventually be converted into 
a more permeable form of H2O2 outside of the cell. As a result, overall ROS levels in either 
the extracellular environment of neighboring cells or in the cytoplasm of ts1-infected cells 
may be increased. We attempted to suppress gp91phox expression using shRNA containing 
lentivirus molecule. Unfortunately lentivirus transduction itself seemed to activate NOX and 
the lentivirus-transduced cells appeared to be ts1-resistant. In other words, for some 
unknown reason, these cells did not show any cytopathic effect as a result of ts1 infection. 
However, we observed that cell growth was decreased in gp91phox shRNA lentivirus-
tranduced cells compared to the control lentivirus-transduced cells (data not shown). We 
suspect that constant ROS production at low levels by small amounts of NOX activity may 
play a mitogenic role. 
 
3.4.1. Subcellular localization of NOX subunits may determine its local activation 
using different subunits 
       gp91phox and p22phox are colocalized at the plasma membrane, whereas the p47phox and 
p67phox subunits are known to be distributed in the cytoplasm without stimulants. In neurons, 
both p47phox and p67phox subunits exhibit punctate staining at the membrane within 4 hours 
after nerve growth factor deprivation (181). Immunodepletion of p67phox from aortic 
fibroblast particulates resulted in loss of NADPH oxidase activity, which could be restored 
by the addition of recombinant p67phox (182). These previous studies support the current 
NOX activation model in which assembly of cytoplasmic p67phox accompanied with its 
partner p47phox and catalytic subunit gp91phox occurs at the plasma membrane. Although 
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expression of NOX subunits has been reported in astrocytes, the distribution of each 
subunit is assumed to be similar to those in macrophages (54). However, in this study, we 
found that p67phox is unexpectedly localized at the membrane fraction whereas p47phox is at 
the cytoplasm without any stimulation. Thus, NOX activation may be more complicated than 
previously assumed. Some members of the NOX catalytic protein family do not require 
p47phox for its activation. It is possible that NOX complex activation may be different 
depending on the subcellular localization of NOX subunits. For example, NOX activity at the 
plasma membrane is decreased by p47phox mutant expression whereas intracellular NOX 
activity during phagocytosis exhibits no change by p47phox mutant expression (183). In our 
study, we observed p47phox translocation in astrocytes only at 24 hpi and not at 4 hours hpi. 
This may imply that NOX activation at 4 hpi is related to a phagocytosis-dependent process. 
Although NOX activation has been reported in various NDs in recent years, mechanisms for 
its activation or deactivation is still unclear. At least three serine phosphorylation sites on 
p47phox by casein kinase 2 (CK2) are identified. Inhibition of CK2 has been shown to 
increase and prolong NOX activity, indicating that p47phox phosphorylation by CK2 
negatively regulates NOX activity. Inhibition of CK2 also enhances p47phox translocation to 
membrane (184). Along with p47phox translocation at 24 hpi, we also observed p47phox 
protein mobility shifted to a lower band. Although we have not investigated whether ts1 
infection suppresses CK2 activity in reference to the p47phox protein band shift, it would be 
interesting to study if the lower p47phox band is dephosphorylated p47phox via suppression of 
CK2 in ts1-infected astrocytes.   
 
3.4.2. NOX isoforms may have distinct functions in different subcellular location. 
       As mentioned before, ts1 has a cytopathic effect on astrocytes due to ER stress 
caused by misfolded env protein (32). Zhao X et al showed that the induction of apoptosis 
in mink epithelial cells by mink cell focus-forming (MCF)-MuLV infection results in the 
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accumulation of high levels of both unintegrated viral DNA and the envelope precursor, 
gPr80env (185). Comparisons of envelope protein expression of MCF-MuLV and 
noncytopathic NZB-9 MuLV strains demonstrate that the accumulation of MCF13 gPr80env 
results in ER stress and is sufficient for the induction of apoptosis (185). ER stress may be 
related to intracellular ROS induction in ts1-infected cells. Due to mutation, the precursor 
viral envelope protein of ts1, gPr80env is unable to fold properly and unable to proceed to 
the Golgi apparatus. The UPR activates NOX, which may be localized to the ER 
membrane. This is notable because endothelial cells have 100 times higher NOX4 
expression compared to NOX2. NOX4 in endothelial cells is predominantly expressed in the 
ER membrane yet not in lysosomes or mitochondria, suggesting that NOX4 may be 
involved in repairing ts1-mediated UPR in endothelial cells (186). This may explain why ts1 
is not cytopathic to endothelial cells. Increased expression of NOX4 in astrocytes may 
prevent neuropathic symptoms facilitated by UPR in the ts1-infected mouse brain.  
 
3.4.3. The complex relationship of ts1 infection, O2-, and neuronal death  
         In this study, we showed that NOX is activated by ts1 infection and NOX activation 
appears to be involved in early virus establishment in the host cells. In fact, little information 
is currently available regarding NOX in the context of retrovirus infection. There are a few 
important observations to be addressed in ts1-infected mouse brain. First, we have 
reported astrogliosis in ts1-infected mouse brain and from this study we know that all 
GFAP- positive cells in ts1-infected mouse brain are not necessarily ts1-infected cells. At 
present, we do not know whether astrocytes become active as a result of ts1 infection, or 
due to migration of uninfected astrocytes to ts1-infected area in order to compensate for 
dysfunctional infected astrocytes. O2- produced by infected astrocytes may function as a 
chemokine to attract uninfected astrocytes. Second, we do not know if prevalent viral 
particles produced by infected cells cause O2- production not only in astrocytes but also in 
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neurons. ts1 is not expected to invade the nucleus in neurons because neurons are not 
mitotic cells. NADPH levels decrease in a NOX-dependent mechanism at 4 hpi, suggesting 
that NOX activation occurs before viral gene integration. Some HIV viral proteins have been 
shown to activate NOX in neurons. O2- upregulation near the perinuclear area in neurons 
may be damaging neurons. Therefore, we cannot exclude the possibility that NOX 
activation in neurons by ts1 particles without viral gene integration may cause O2- 
upregulation, leading to neuronal death in the ts1-infected mouse brain. Thirdly, ts1-infected 
astrocytes may not be the cells that produce viral progeny actively in the CNS. If 
extracellular O2- or other ROS from astrocytic NOX activation damages nearby neurons, 
ts1-infected neuron degeneration may be recovered by thiol supplements including GSH (5) 
(126).  
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Chapter 4. Conclusion and future direction 
 
       Throughout the history of retrovirology, paradigm shifts have been observed as new 
discoveries are made. The first major finding was the discovery of animal-infecting 
retroviruses including RSV and MuLV, second was the development of the viral assay, and 
third was the identification of reverse transcription. The most recent paradigm change in 
retrovirology followed the discovery of human retroviruses, most notably HIV. The discovery 
and investigation of retrovirus-induced human disease models, including the struggle 
against AIDS, would have been significantly delayed if not for the knowledge and tools 
created from years of research on animal retroviruses, which provided the basic framework 
for human retroviruses. Unfortunately, the research limitations for human retrovirus-induced 
diseases have created a challenge for investigators analyzing the mechanism of 
pathogenesis in the whole body system. Ethics and safety standards make studies on 
human subject impossible. Therefore, studies of retrovirus-mediated pathogenesis in 
animal models are extremely valuable. In contrast to cytopathogenesis caused by 
retroviruses, retrovirus-induced pathogenesis in its early and middle stages is esoteric. 
Incomplete understanding of viral establishment and replication in host cells, cellular 
susceptibility, and communication between infected cells and uninfected cells may hinder 
the development of effective therapeutic treatments. Therefore, establishement of 
retrovirus-infected animal models with pathogenic symptoms is crucial.  
 
4.1. Conclusion 
 
       Previous studies in our laboratory demonstrated that ts1 infection exerts different 
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effects upon various cell types in the CNS. While there is no significant inflammatory 
infiltration in the ts1-infected brain, there is consistent appearance of astrogliosis. Neuronal 
death was also evident in ts1-infected brain although ts1 does not infect neurons. 
Additionally, it was demonstrated that ts1 infection causes signs of oxidative stress in the 
brain and astrocytes in culture. For example, depletion of reduced thiols and ROS 
upregulation have been reported in ts1-infected astrocytes (5). Recently cocultures of 
infected astrocytes and neurons demonstrated that drastic upregulation of ROS and 
caspase activation occurred in neurons as a result of ts1-infection in astocytes, indicating 
that neuronal loss may be a consequence of dysfunctional astrocytes (126). Minocycline 
treatment was also shown to suppress ROS upregulation significantly in both ts1-infected 
astrocytic cells alone and neurons cocultured with the infected astrocytes. Another 
antioxidant, MSL, also extends the life span of ts1-infected mice by suppressing oxidative 
stress and decreasing virus titer in the brain (94). However, antioxidant treatment does not 
function as an anti-viral agent but does decrease viral replication by suppressing ROS 
levels. Therefore, we hypothesized that retrovirus-induced ND may not be directly caused 
by neuronal infection. Instead, astrocytes acting as caretakers for neurons provide an 
antioxdiant defense and ts1 infection makes the astrocytes dysfunctional. This change in 
microenvironment appears to be the cause of neuronal death. 
       As noted before, ts1 infection has a cytopathic effect on astrocytes. Previous studies 
have been more focused on virus-mediated oxidative stress and mitochondria-mediated cell 
death processes. In this study, we proposed that dual faces of ROS upregulation are 
involved in retrovirus-induced host cell signaling that may affect cell fates. We thus 
investigated the life cycle of the retrovirus ts1 in the context of ROS upregulation. In 
Chapter 2, we demonstrated that ts1 infection induces two distinctive ROS upregulations in 
astrocytes. The first ROS upregulation, which is relatively low level, occurred in early stage 
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of infection. This early ROS upregulation seems to activate host cells to facilitate viral gene 
integration. Despite its well-known role in apoptosis, p53 appears to play an important role 
in cellular anti-oxidant defense in ts1-infected astrocytes. As a result of ROS upregulation 
during the early phase of ts1 infection, p53 activation suppresses the upregulation of NOX. 
In the absence of p53, expression of viral proteins in host cells occurred earlier in cells 
exhibiting normal p53 expression. Another important finding of our study is that NOX seems 
to play an important role in the early ROS production. In Chapter 3, we demonstrate that 
NOX is activated by ts1 infection in the early stage of infection and inhibition of NOX 
decreases viral DNA integration into the host genome. The second round of ROS 
upregulation takes place in the late stage of infection, following ts1 establishment and 
protein synthesis in the host cells. Due to a single amino acid substitution on the envelope 
protein, the precursor envelope protein does not fold properly and therefore accumulates in 
the ER, resulting in cell death. As a consequence cells die. The second ROS upregulation 
appears to play an important role in mitochondria-mediated apoptotic processes.  
       Overall this study establishes three important aspects of cellular ROS upregulation in 
retrovirus-infected CNS cells. First, this study shows that retrovirus infection actively adapts 
the changes in host intracellular environment. Earlier perspectives on ROS upregulation are 
mainly based on the passive relationship between retrovirus and the host cell, suggesting 
that retroviral infection is dependent on host cell cycle status. However, we discover that 
the interaction between retrovirus and the host cells is rather mutual. Until this point, the 
question of whether a retrovirus actively participates in changing the host intracellular 
environment has not been explored. It is known that various ROS levels can drive different 
cell fates. Low levels of ROS can induce proliferation whereas moderate levels of ROS 
cause growth arrest, and high levels of ROS can cause cellular death (Figure 1.5). In order 
to establish itself in the host cell, retrovirus may utilize the host cells’ defenses to integrate 
viral genes into the host genome by activation of endogenous NOX. Cells that are arrested 
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in G1/S transition have been shown to be much less efficiently infected by MuLV and 
lentivirus (90). In this study, we demonstrate that retrovirus invasion increases low levels of 
ROS in astrocytes during the early phase of life cycle. Retroviruses may actively promote 
ROS levels to overcome the quiescent environment of cells in the CNS, and host cells may 
activate p53 in an attempt to suppress ROS upregulation as a self-defense strategy. 
Secondly, this study explores the importance of temporal and spatial regulation of ROS in 
retrovirus-infected astrocytes. As mentioned earlier, all ROS are not equal. The locations 
and the timing of ROS upregulation appear to be very precisely regulated in different phase 
of the virus life cycle. The first wave of ROS upregulation by NOX and SOD occurs in the 
cytoplasm before the viral gene is integrated into the host genome. After the viral gene is 
integrated into host genome, the second wave of ROS appears at the plasma membrane 
by NOX, which is not associated with ER stress. The third wave of ROS production is from 
the mitochondria, followed by activation of cell death. We distinguished at least three 
different locations and timing of ROS production and observed that each ROS upregulation 
does not last throughout the entire retrovirus life cycle. Most studies on ROS and their 
effects may use too high concentrations compared to the ROS concentrations in 
physiological conditions. ROS are generally unstable and react quickly with cellular 
molecules, which are in some cases at unintended locations. Thus, to investigate the 
effects of ROS on physiological conditions, a system that activates endogenous ROS 
production is necessary. We demonstrate that ts1-infected astrocytes can provide useful 
tools to study the effects of ROS on astrocytes. Most importantly, ROS upregulation may 
generate different cellular effects depending on the location and concentration. Third, tissue 
staining using DHE fluorescence shows that neurons as well as ts1-infected astrocytes in 
the mouse CNS are under oxidative challenge as a result of ts1 infection (Figure 3.10). 
Neurons are specialized in their function. Their redox balance and metabolism are primarily 
supported by nearby astrocytes, more specifically by providing reduced thiols for anti 
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oxidant defense. In particular, the metabolism of neurons depends heavily on mitochondria. 
Therefore, antioxidant defense is critical for the elimination of mitochondrial respiratory 
byproducts. This study, as well as previous work from our lab, substantiates that ts1 
infection reduces the precursor of GSH (cysteine) and GSH levels, therefore increasing 
ROS levels. Furthermore, ts1-infected astrocytes can release O2- into the extracellular 
environment, which may directly damage neurons. Many neurodegenerative diseases are 
associated with oxidative stress, and thereby, ROS upregulation by dysfunctional 
astrocytes may also be applicable to other neurodegenerative disease models. 
       The regulation of intracellular or extracellular ROS levels is unlikely to be orchestrated 
by one simple signaling pathway, but rather by a complex signaling network. In this study, 
we investigated that NOX, SOD and p53 play important roles in the ROS regulation using 
the ts1-infected astrocyte system.  
 
4.2. Proposed model and future studies. 
 
       ROS research is an inherently challenging field due to the transient nature of ROS. The 
concept that ROS play different roles in cellular processes at different concentrations and 
locations has been proposed. Moreover, cellular redox status may vary between cell types 
in order for the different cells to optimally perform their functions. Here we have described 
ROS upregulation during retrovirus infection and illustrate its complexity. As mentioned 
above, the timing of ROS upregulation is associated with different phases of the virus life 
cycle. To investigate how each ROS upregulation contributes to the retrovirus life cycle, 
modulation of p53, SOD and NOX are essential. Based on the observations from Chapter 2 
and 3, we proposed a model of ROS upregulation in ts1-infected astrocytes. It may be 
summarized by the activation of NOX by retroviral invasion at the plasma membrane and 
the fusion of the viral receptor with viral envelope protein forms vesicles either as a 
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phagosome or an early endosome. As a first line of defense, SOD is quickly upregulated 
and catalyzes O2- to H2O2. Therefore, 4-8 hpi, the H2O2 increase is observed. In the 
vesicles, retrovirus may develop a system to adapt the ROS by modulating PIC 
components to facilitate integration into the host genome. H2O2 is more membrane 
permeable than O2-, and therefore, cytoplasmic H2O2 may increase concomitantly with the 
rise of H2O2 in the vesicles and activation of cytoplasmic p53. Activated p53 downregulates 
NOX expression levels via a negative feedback mechanism. It is important to validate the 
sequential processes during the different phase of ROS upregulation in the life cycle of 
retrovirus.  
       Furthermore, ROS upregulation by retrovirus-infected astrocytes plays an important 
role in neuronal death. It is crucial to investigate which phase of ROS upregulation is 
associated with neuronal death to identify the most efficient therapeutic targets. Throughout 
this study, we demonstrated three different ROS upregulations from different sources. 
However, at present, we do not know whether ROS upregulation by ts1-infected astrocytes 
is associated with a direct or indirect killing mechanism of nearby neurons. The effect of 
ROS upregulation in the CNS can be summarized into three possibilities. First, ROS 
upregulation facilitates retroviral replication in the CNS. As we have shown in this study, 
ROS upregulation in the early phase of infection is associated with viral establishment. 
Targeting this step will decrease dissemination of progeny viruses and prevent further 
infection. Second, decreased antioxidant defense and increased ROS in the 
microenvironment may make neurons vulnerable, and consequently lead to cell death. We 
demonstrate a prevalence of O2- upregulation in the ts1-infected mouse CNS and in the 
extracellular environment of ts1-infected astrocytes in culture. Previous studies in our 
laboratory have shown that the depletion of reduced thiols in ts1-infected astrocytes 
cultures and decreased cysteine levels in ts1-infected brain slice culture (Lungu Gina, 
unpublished data). However, these signs of oxidative stress are not defined in the context 
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of the ts1-infected astrocytes status. Third, ROS upregulation in ts1-infected astrocytes may 
disrupt its endogenous functions, for example recycling glutamate and providing nutrients. 
Previously, it has been reported that ROS upregulation can change GS expression in 
astrocytes. An abundance of the excitatory neurotransmitter glutamate in the extracellular 
environment is capable of inducing neuronal cell death. Further studies exploring the direct 
or indirect effect of astrocytic ROS upregulation would be beneficial in the development of 
an effective therapeutic target and in the understanding of other neurodegenerative models 
associated with oxidative stress. ROS regulation at multiple levels compounds the difficulty 
of data interpretation. Possible overlapping of the different phases in culture adds 
substantial technical challeges that may affect an overall study of the role of ROS 
upregulation in the life cycle of the retrovirus. These studies offer new insights into the 
mechanisms for retrovirus-host cell interaction that facilitate or inhibit viral replication, in 
particular during the early phase of infection. Better understanding of the cellular ROS 
regulation system would lead us to opportunities for suppression of permanent retrovirus 
establishment in the host cells. Furthermore the knowledge gained from this study will help 
us to develop therapeutic strategies to influence the course and outcome of diseases 
caused by retrovirus-infection.  
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